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Proteins of Mycobacterium tuberculosis. 
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In bacteria, most secreted proteins are exported through the SecYEG 
translocon by the SecA ATPase motor via the general Sec pathway. The 
identification of an additional SecA protein, particularly in Gram-positive 
pathogens, has raised important questions about the role of SecA2 both in 
protein export and establishment of virulence. In Mycobacterium tuberculosis, the 
causative agent of Tuberculosis (TB), the accessory SecA2 protein possesses 
ATPase activity that is required for bacterial survival in host macrophages, 
highlighting its importance in virulence. This study probes the biochemical 
differences between the two SecA proteins in order to gain insight into how they 
interact with the same translocon to exporting specific precursors. The study 
shows that SecA2 unlike SecA1 does not associate with the membrane under 
normal conditions. SecA2 also binds ADP with much higher affinity than SecA1 
and releases the nucleotide more slowly. Nucleotide binding regulates movement 
of the precursor-binding domain in SecA2, unlike in SecA1 or conventional SecA 
proteins. This conformational change involving closure of the clamp in SecA2 
may provide a mechanism for the cell to direct protein export through the 
conventional SecA1 pathway under normal growth conditions while preventing 
ordinary precursor proteins from interacting with the specialized SecA2 ATPase. 
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Chapter 1 
INTRODUCTION 
A. Sec dependent protein secretion- an overview 
 In bacteria, about a third of the proteome is secreted. In order to export 
these proteins from the cytoplasm, bacteria have evolved several export 
pathways, of which the ‘Sec’ pathway is the only one that is essential for cell 
viability in bacteria, archaea and fungi (1). This pathway is comprised of a single 
essential SecA ATPase, the SecYEG translocon and several accessory proteins 
(2-4). A protein that is destined to be exported, is called a ‘precursor-protein’ or 
‘pre-protein’ and is synthesized with an N-terminal signal sequence, which serves 
as an ‘address tag’ that directs its route to the SecYEG translocon (5). These 
‘tags’ are around thirty amino acids in length and are surprisingly not conserved 
but highly variable. The signal sequence has a tripartite structure, comprised of a 
positively charged amino terminus, a hydrophobic core and a polar carboxyl end 
region that contains the sequence for recognition and cleavage by signal 
peptidase once exported (6). Pre-proteins are faced with several different export 
routes depending on whether their final destination is the integral membrane, 
periplasm, outer membrane or extra-cellular milieu. Based on certain features of 
the nascent chain, the SecYEG translocon facilitates the export of precursors in a 
co-translational or post-translational manner (7,8) (Figure 1-1).  
Co-translational translocation 
Precursors that are destined to be membrane proteins have extremely 
 2 
hydrophobic signal sequences. A ribonucleoprotein complex called SRP (signal 
recognition particle) associates with the ribosome and is thought to ‘screen’ the 
nascent chain of a pre-protein as it emerges from the ribosome exit tunnel. SRP 
then binds to highly hydrophobic signal sequences with high affinity, forming the 
RNC (ribosome nascent chain)-SRP complex (9-11). In bacteria, this complex is 
recruited to the SRP receptor FtsY where it is stabilized by the GTPase domains 
of SRP and the receptor (12,13). FtsY possesses an acidic domain that interacts 
with the SecYEG translocon (14). The cargo RNC is then delivered by FtsY to 
the SecYEG translocon in a step involving GTP hydrolysis (13,15). Hydrolysis of 
GTP enables disassembly of the SRP-receptor complex facilitating the recycling 
of SRP (16). 
Post-translational translocation  
General pre-proteins once synthesized, must be maintained unfolded in 
order to be exported by the SecYEG translocon (17). This function is fulfilled by 
several chaperones such as Trigger factor, DnaK, GroEL and SecB (in case of 
Gram negative bacteria), which associate with the pre-protein after its 
emergence from the ribosome exit tunnel. SecB, however, is a unique chaperone 
because not only does it prevent folding of the pre-protein but also targets it to 
the SecA ATPase by directly binding to SecA itself (18). SecB is a tetramer, 
comprised of a dimer of dimers (19). A surface exposed groove is present which 
is hydrophobic and is thought to bind the signal peptide (18). The mechanism for 
recognition of pre-proteins by SecB is not well understood, however a ‘kinetic 
partitioning’ model for the same has been put forth, based on interaction of SecB 
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with maltose-binding protein (MBP) (20). Since SecB can interact with the 
precursor form of MBP or slow folding mutants of MBP, but cannot interact with 
mature MBP or other proteins with a fast folding rate, the model suggests that 
association of SecB with precursors is dependent on the rate of folding of the 
precursor. Since the signal peptide has been shown to slow down the folding rate 
of a precursor, association of precursors with SecB is favored (20,21). SecB 
delivers the unfolded pre-protein to the SecA ATPase by directly interacting with 
SecA. The extreme C-terminus of SecA is involved in SecB binding and is highly 
conserved (22). This site is positively charged and also comprises a zinc-binding 
site that is important for binding to both SecB and anionic phospholipids (23). 
SecA is a homodimeric protein that binds to to both the signal sequence and 
mature regions of pre-proteins (24) and targets them to the membrane. SecA 
also binds to the SecYEG translocon with high affinity (25) (Table 1-3) and drives 
the export of the unfolded precursor across the translocon using the energy of 
ATP hydrolysis and the proton-motive force (PMF) (26) (Figure 1-1). The 
translocon is a heterotrimeric protein complex that is made up of the main 
channel protein SecY that is comprised of ten transmembrane segments (TMSs), 
SecE and SecG. TMS 1-5 and 6-10 of SecY are arranged to resemble a 
clamshell (27) (Figure 1-2). The hinge between the two halves of the clamshell 
structure is provided by two helices of SecE that give the translocon its flexibility 
and stability. Opposite this hinge is a potential opening between TMS 2 and TMS 
7 referred to as the ‘lateral gate’. This feature is thought to enable the translocon 
to open laterally into the membrane for insertion of membrane proteins. The 
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lateral gate has been shown to widen to different extents to translocate a range 
of pre-proteins that differ in amino acid composition (28). The SecG protein also 
interacts with SecY and forms part of the translocon but is not essential for 
translocation; however it enhances translocation efficiency (29). The overall 
structure of the translocon is that of an hourglass. At the constricted region, six 
hydrophobic residues are present that form a seal to provide a barrier for small 
molecules and ions. This is referred to as the ‘pore ring’ (30). Below the pore ring 
is a short helix called the ‘plug’. Although the plug is not essential for cell viability 
or translocation, its role is to further seal the channel to water, small molecules 
and ions (30). The plug is thought to sense the hydrophobicity of the nascent 
polypeptide chain being translocated so that it can be displaced by hydrophilic 
polypeptide chains but would block hydrophobic polypeptides, potentially 
directing such segments into the membrane via lateral translocation (31). 
SecYEG has been shown to associate with other membrane protein complexes 
SecDFYajC and YidC for the export of some pre-proteins (32,33).  
Once the pre-protein is translocated across the SecYEG pore, the signal 
sequence is cleaved by signal peptidase (SPaseI) if the final destination of the 
protein is the periplasm, and the mature protein folds with the assistance of 
periplasmic chaperones in case of Gram-negative bacteria (34). In case of outer 
membrane or lipoproteins, the pre-protein is further directed by chaperones to 
the BAM (β-barrel assembly machinery) (35) or LOL (lipoprotein outer membrane 
localization) complexes respectively (36). In some cases pre-proteins are 
exported across the outer membrane into the extracellular milieu.  
 5 
 
Figure 1-1: Graphical representation of co and post-translational 
translocation by the Sec pathway.  
Detailed description can be found in the text. 
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Figure 1-2: Structure of the SecYEβ translocon of M. jannaschii  PDB ID 
1RHZ (37).  
The structure has been modified using Chimera (38) to show the side view (A) 
and top view from the cytosol (B). The SecY protein is show in dark gray, SecE in 
majenta and SecG (β) in deep cyan. The plug helix of SecY is shown in red.  
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B. Accessory Sec systems in bacteria 
Even after decades of research on the Sec-dependent pathway, it was 
believed that bacteria had only a single essential SecA ATPase protein. In the 
past decade however, advances in proteomics and whole genome sequencing 
led to the identification of an additional secA gene in several Gram-positive 
bacteria. This additional SecA homolog called SecA2, is functionally distinct from 
SecA1 and has been shown to be a more specialized SecA protein, required for 
the export of only a subset of precursor proteins (39-42). Further research on the 
accessory SecA protein led to the broad classification of these systems into: 
1) SecA2 only secretions systems 
2) SecA2/Y2 secretion systems 
SecA2 only secretion systems 
These systems are found in bacteria like Mycobacteria, Corynebacteria and 
Listeria that have a SecA2 homolog but lack an additional SecY protein or other 
accessory secretion factors. In these systems the SecA2 protein is thought to 
function with the canonical SecYEG translocon either independently or in concert 
with SecA1. In Mycobacteria and Listeria, secA2 is not essential but in pathogens 
like Mycobacterium tuberculosis (Mtb) and Listeria monocytogenes deletion of 
secA2 attenuates virulence (39,43). However; in Corynebacterium glutamicum 
and Clostridium difficile SecA2 was found to be essential for viability (44,45). 
Precursor proteins that require SecA2 for export have been identified in 
Mycobacteria, Listeria and Clostridia (Table 1-1). Some of these pre-proteins 
 8 
resemble a conventional Sec-dependent precursor and have a signal sequence 
while some of the pre-proteins do not (46).  
SecA2/Y2 systems 
Bacteria such as some Streptococci and Staphylococci that possess such 
systems, contain an additional SecY protein that is thought to function as a 
translocon in concert with the SecA2 protein. Unlike the loci in the ‘SecA2 only’ 
systems, the SecA2/Y2 genomic locus is highly conserved in bacteria possessing 
such systems (Figure 1-3). Additionally, such genomic loci also encode related 
genes such as genes encoding for SecA2-dependent substrates, enzymes 
involved in glycosylation of such substrates prior to export as well as accessory 
secretion proteins that associate with SecA2 or SecY2. Proteins that are 
exported by the SecA2/Y2 system are heavily glycosylated and cannot be 
exported by the conventional SecA1/YEG pathway (41). For each polypeptide 
backbone of GspB, a SecA2-dependent substrate, around 100 monosaccharide 
residues are added (47). These proteins are called serine-rich repeat (SRR) 
glycoproteins and have an unusually long N-terminal signal sequence (~ 90 
amino acid residues) but possesses the characteristic tri-partite nature of the Sec 
signal sequence. This N-terminal region of the signal sequence has a 
KxYKxGKxW motif that is unique and predicted to be important for targeting the 
pre-protein to the membrane (48). The signal sequence is followed by an 
accessory Sec transport (AST) domain that is not conserved but required for 
SecA2/Y2 export (49), a short SRR region, a ligand binding region, a long SRR 
and a C-terminal LPXTG motif that is required for anchoring to the cell wall (50). 
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The mature region of the protein gets glycosylated at the SRR regions although 
the type of glycosylation and structure of the glycan is not yet known. Even 
though glycosylation is not required for SecA2/Y2 export, the addition of 
carbohydrate moieties distinguishes these pre-proteins from typical Sec-
dependent precursors in stability, solubility, protease resistance and binding 
properties (50) and prevents them from being exported by the general 
SecA1/YEG pathway.  
The SecY2 protein of the SecA2/Y2 system shares low sequence 
similarity to its SecY counterpart (20% identity, 60% similarity) but is expected to 
form a channel like SecY. The cytosolic loops in SecY that are important for 
SecA interaction are absent in SecY2, indicating that it probably does not interact 
with conventional SecA proteins. Pore ring residues of SecY2 consist of Leu and 
Met instead of Ile as in the case of SecYEG. There is no feature in SecY2 that 
would suggest any unique interaction with glycosylated substrates. In case of the 
conventional SecY protein, SecE is required for stabilizing the translocon. Two 
unique proteins Asp4 and Asp5 that have predicted transmembrane segments 
are thought to take the place of SecE and SecG in the SecA2/Y2 system (51). In 
addition to Asp4 and Asp5, bacteria that have SecA2/Y2 systems also have Asp 
or Gap (accessory secretion proteins or glycosylation associated protein) 1, 2 
and 3 proteins. These proteins are thought to play an important role in SecA2/Y2 
mediated export. Asp2 and 3 have been shown to bind to SecA2 as well as 
unfolded pre-proteins (52). In GspB, these proteins bind to the SRR regions (53).  
The SecA2 proteins in such systems are smaller than their SecA homologs due 
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truncation of 45 C-terminal residues. They also have a proline residue at the C-
terminus. They are around 70 % similar (~40 % identical) to their corresponding 
SecA homologs and most of the similarity lies in the motor domains. Nucleotide 
binding and hydrolysis is required for SecA2-dependent export (54). The SecA1 
and SecA2 homologs are not interchangeable, suggesting a distinct role for 
SecA2 in pre-protein export. The SecA2 proteins in this system appear highly 
specialized for the export of their respective unique glycosylated pre-protein as S. 
pneumoniae SecA2 cannot export GspB in S. gordonii despite 79% sequence 
similarity (61% identity) between S. pneumoniae SecA2 and S. gordonii SecA2. 
Further, S. sanguinis SecA2 can only partially complement a S. gordonii ∆secA2 
strain despite 91% similarity (81% identity) between S. sanguinis SecA2 and S. 
gordonii SecA2. 
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Figure 1-3: Genetic loci encoding secA2 in bacteria containing SecA2 only 
as well as in bacteria containing SecA2/Y2. 
 12
The figure has been modified from Bensing et al. (50) to show gene organization 
in bacteria with SecA2 systems only, where the genomic locus is not conserved 
and contains genes encoding for SecA2-dependent pre-proteins in some cases 
as well as genes encoding proteins unrelated to the Sec system. On the other 
hand, in the SecA2/Y2 containing organisms, the genetic loci are highly 
conserved and contain genes directly involved in SecA2-dependent export such 
as genes encoding SecY2, pre-proteins and glycosylation enzymes. 
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*SecY2 present but not essential for SecA2-dependent export, also genetic locus is more similar to SecA2 only bacteria. 
 
 
 
 
Table 1-1: List of pre-proteins identified to date that require SecA2 for 
export in bacteria that have ‘SecA2 only’ secretion systems.   
Organism Protein (s) 
exported 
Signal  Function/Predicted 
Function 
Refer-
ence 
    
Mycobacterium tuberculosis Fe-superoxide 
dismutase (sodA) No 
Removal of 
reactive oxygen 
species, virulence 
factor 
(39) 
Mycobacterium smegmatis Msmeg 1704 
Msmeg 1712 
            Yes 
Yes 
Sugar binding 
lipoproteins 
(40) 
Mycobacterium marinum Protein kinase G 
(PknG) 
No Virulence factor (55) 
Listeria monocytogenes p60 
NamA 
 
Mn-superoxide 
dismutase (sodA) 
 
Lap (Listeria 
adhesion protein) 
 Yes 
 Yes 
 
 
No 
 
 
No 
Peptidoglycan  
hyrolysis 
 
 
Removal of 
reactive oxygen 
species 
 
Promotes 
paracellular 
translocation of 
Listeria 
(56) 
 
 
 
(57) 
 
 
(58) 
Clostridium difficle S-layer protein A 
(SlpA) 
 
Cell wall protein 
(CwpV) 
 
 
Yes 
 
 
Yes 
Outer layer 
protein, adhesion 
 
Auto-aggregating 
factor 
(45) 
Bacillus anthracis* S-layer proteins  Yes Outer layer 
proteins, adhesion 
(59) 
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  *Not located within the SecA2 locus, and not a serine rich glycoprotein  
 
Table 1-2: List of pre-proteins identified to date that require SecA2 for 
export in bacteria that have ‘SecA2/Y2’ secretion systems.   
 
 
 
 
 
Organism Protein(s) 
exported 
Signal          Function/
Predicted 
Function 
Reference 
Streptococcus gordonii GspB  
(surface 
glycoprotein) 
Yes Platelet 
binding 
protein 
(41) 
Streptococcus parasanguinis Fimbrial adhesion 
protein (Fap1) 
 
FimA* 
Yes Adhesion 
 
 
Surface 
protein 
(60) 
Streptococcus agalactiae Serine-rich repeat 
glycoprotein (Srr1) 
Yes Binds  
human 
fibrinogen 
(61) 
Staphylococcus aureus Serine-rich adhesin 
for platelets (SraP)  
Yes Platelet 
binding 
(62) 
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C. The SecA motor 
The SecA protein is a member of the superfamily 2 DEAD (DExH/D) 
proteins that include DNA and RNA helicases (63). The nucleotide-binding 
domain (NBD) is made up of two RecA like folds that contain Walker A and 
Walker B motifs that are important for ATP binding and hydrolysis. In addition to 
the nucleotide binding domains, SecA contains a pre-protein binding domain 
(PBD or pre-protein cross-linking domain PPXD) (64,65) that has been shown to 
bind precursor proteins and a C-terminal region that is comprised of a helical 
wing domain (HWD), C-terminal linker (CTL) that contains a Zn ion (23) and is 
important for SecB and lipid binding (22,66) and a helical scaffold domain (HSD) 
(Figure 1-4).  
SecA binds ATP with high affinity (Table 1-3), between nucleotide-binding 
fold 1 (NBF1 or NBD1) and nucleotide-binding fold 2 (NBF2, NBD2 or intra-
molecular regulator of ATPase IRA2). ADP release from SecA is the rate-limiting 
step in catalysis (67-69). Association of SecA with SecY enhances ADP release, 
however ADP-release still remains rate-limiting (68,70). The ADP-release rate is 
greatly enhanced when SecA is bound to a pre-protein such that the population 
of SecA:ADP is shifted to a species rapidly inter-converting between SecA:ATP 
and SecA:ADP (68). In cytosolic SecA, the ‘basal’ ATPase activity is low in the 
absence of a bound pre-protein. This inhibition is due to a helix-loop-helix 
structure in the HSD also called the intra-molecular regulator of ATPase 1 (IRA1) 
that contacts both NBD2 and the PPXD (71). This IRA1 region is thought to 
stabilize the ADP bound form of the protein, thereby preventing futile ATP 
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hydrolysis. On binding pre-proteins, the ATPase activity of SecA is enhanced via 
a conserved salt bridge called ‘Gate 1’ that regulates the opening and closing of 
the nucleotide binding pocket (72). 
Since SecA binds to several translocation ligands (Table 1-3), it 
undergoes different conformational changes (71,73,74). Most crystal structures 
of isolated SecA show the PPXD in close proximity to the HWD (73,75). The 
most dramatic conformational change in SecA is one revealed by the crystal 
structure of Thermatoga maritima SecA bound to the translocon. This structure 
shows the PPXD rotated all the way toward NBD2 (74). This groove formed 
between the PPXD and NBD2 is referred to as the ‘clamp’. The clamp contains 
conserved hydrophobic residues and is thought to hold the precursor protein in 
position (74) as it aligns the PPXD of SecA with the SecY translocon. SecA is 
thought to bind to precursors in the ‘open clamp’ conformation. Disulfide 
crosslinking experiments, as well as a structure of B. subtilis SecA with a 
hydrophilic peptide (PDB ID 3JV2), reveal that the pre-protein moves through the 
clamp of SecA (76). It is not yet known what regulates the movement of the 
PPXD that leads to opening or closing of the clamp in conventional SecA 
proteins. Two beta strands between the PPXD and NBD1 are thought to be 
important for interaction with the polypeptide backbone (76). Further insight into 
the SecA:precursor interaction comes from an NMR structure of SecA bound to a 
signal peptide from the LamB porin, KRR-LamB solved by transferred nuclear 
Overhauser effect spectroscopy (trNOESY) (77). The signal peptide was found to 
adopt an α-helical conformation and bind in the hydrophobic groove (clamp) of 
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SecA. Another interesting feature revealed by this structure was that the C-
terminal region of SecA was found to obstruct the groove, consequently 
preventing signal peptide binding. This inhibition was overcome by SecB binding, 
resulting in an increased affinity of SecA for the signal peptide. Another important 
feature of SecA revealed in this structure is with respect to its helix-loop-helix 
(two-helix finger or arginine finger), earlier identified as IRA1. This two-helix 
finger dips into the SecY channel in a manner that the loop connecting the 
helices is positioned above the SecY pore suggesting a role for threading pre-
proteins through the channel (74,78). Disulfide cross-linking experiments 
revealed that this region makes important contacts with the pre-protein and was 
hypothesized to move up and down dragging the pre-protein through the SecY 
pore (78). A later study showed that the arginine finger does not move during 
translocation, suggesting a different role for the finger such as opening the 
channel or simply just preventing back-sliding of the pre-protein during 
translocation (79). 
The cytoplasmic concentration of SecA is around 8 µM (80) creating a 
large excess of SecA relative to SecYEG (13,000 copies of SecA compared to 
500 copies of SecYEG) (63). With a dissociation constant of < 1 nM, significantly 
lower than the cytosolic concentration of SecA in E. coli, SecA is expected to be 
predominantly dimeric in the cytosol (81). SecA, however, has been shown to 
monomerize upon interaction with certain components of the translocation 
machinery (82,83), leading to a debate on the oligomeric state of the protein 
during translocation. Several SecA proteins from E. coli as well as other 
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organisms have been crystallized as dimers, but the positions of each monomer 
with respect to the other is different in each of the structures. Most form anti-
parallel dimers in which the C-terminal domains face away from each other, in 
opposite directions (84).  
Biochemical studies have shown that high protein concentrations, 
temperature and low ionic strength favor dimerization while increasing ionic 
strength favors monomerization (81,85,86). This suggests that the dimer 
interface is probably stabilized by electrostatic and hydrophobic interactions. 
Recent biochemical studies reveal two helices (called α0 and α1) at the extreme 
N-terminus of one SecA protomer form dimer contacts with C-terminal residues 
of the second protomer (87). The helix α0 forms hydrophobic contacts while α1 
forms stronger electrostatic interactions. The study shows that these dimer 
contacts enable SecA to adopt several states with different orientations of the 
protomers.  
Several models have been proposed to explain translocation of pre-
proteins by SecA. Two of popular models are the ‘power-stroke model’ and the 
‘Brownian rachet model’. The power-stroke model suggests that ATP binding and 
hydrolysis by SecA would induce conformational changes in SecA and cause it to 
exert a mechanical pushing force to direct precursors across SecY. The 
Brownian rachet model suggests that precursors pass through SecY by Brownian 
motion and back-sliding is prevented in an ATP-dependent manner by SecA (27).  
Models have also been put forth by dissecting the translocation steps 
 19
further and suggest that dimeric SecA associates with SecYEG but only one 
protomer docks at the translocon. The association of ‘peripheral’ protomer with 
the docked protomer is salt-sensitive. Docking of the SecA dimer to SecY causes 
the dimer to become asymmetric and increases the affinity of the docked 
protomer for the pre-protein (Table 1-3). Once SecA binds a signal peptide, a 
conformational change is triggered in the SecA dimer causing it to become 
elongated. This conformation has been referred to as the ‘triggered dimer’. These 
changes are relayed on to SecY, causing its pore to open. ADP is exchanged for 
ATP but hydrolysis is prevented due to the presence of the bound signal peptide. 
SecA could partially insert into the channel triggering ATP hydrolysis, which 
would cause SecA to monomerize and trap the mature region of precursor 
nascent chain in the translocase. Monomeric SecA would complete the 
translocation of the precursor across SecY (although the exact stage at which 
SecA monomerizes is debated in the field). Once the protein is translocated, 
SecA would loose affinity for SecY and re-dimerize in solution. 
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Figure 1-4: Structure of E. coli SecA 
The E. coli SecA structure in its apo form is shown in ribbon representation (left) 
and surface representation (right). The structure was made using Chimera, 
based on the coordinates deposited in the Protein Data bank (2FSF) (88) and 
has been modified to show only one protomer. The nucleotide binding domains 1 
(NBD1) (NBD2) are shown in dark and light blue respectively and the pre-protein 
binding domain (PPXD) is in red. The C-terminal domain is further divided into 
the helical scaffold domain (HSD) in green and the helical wing domain (HWD) in 
yellow. The intra-molecular regulator of ATPase region (IRA1) that is part of the 
scaffold domain is shown with an arrow. The groove formed between the PPXD 
and NBD2 called the ‘clamp’ is shown with an arrow in the surface representation. 
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Table 1-3: Binding affinities of SecA for different ligands important in Sec- 
dependent protein translocation. 
Interaction Kd Reference 
SecA:SecA 
 
0.7 nM (81) 
SecA:SecB 
 
1.6 µM (89) 
SecY-SecA:SecB 
 
30 nM (90) 
SecY-SecA:SecB-preprotein 
 
10 nM (91) 
 
 
SecA:preprotein (proPhoA) 
 
3 µM  
 
(24) SecA:signal sequence (proPhoA) 
 
32 µM 
SecA: mature protein (proPhoA) 
 
7 µM 
SecY-SecA:preprotein (proPhoA) 
 
0.23 µM 
SecY-SecA:mature protein 
(proPhoA) 
 
0.6 µM 
 
 
SecA.Mg2+ : ATP 
 
0.32 µM (69) 
SecA:SecY 
 
~3-4 nM (81) 
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D. The Mycobacterial Sec system 
 
Sequencing of the Mycobacterium tuberculosis (M. tb) genome in 2000 led 
to the identification of the secA2 gene, the first SecA2 homolog to be reported 
(92). In Mycobacteria, secA1 was found to be essential for viability suggesting 
that it is the ‘house-keeping’ SecA and likely functions in a manner similar to E. 
coli SecA. Further studies revealed that secA1 and secA2 are not 
interchangeable (92); however M. smegmatis secA2 can substitute for M. tb 
secA2 during growth of M. tb in macrophages. Further, M. smegmatis SecA2 can 
also restore the rough colony phenotype to a M. tb ∆secA2 strain, which shows a 
smooth colony phenotype unlike the rough colonies produced by a wild type M. 
tb strain. Full length M. tb secA1 cannot compensate for a temperature-sensitive 
defect of an E. coli SecA ts strain but when the first 225 amino acid residues of M. 
tb SecA1 were fused to the remaining region of E. coli SecA (225-901), the 
chimeric protein was able to grow at non-permissive temperatures (93) 
suggesting that the C-terminal regions of SecA proteins responsible for 
interaction with SecY and lipids have evolved for interaction of the SecA protein 
with its own specific bacterial membrane making it unique.  
 Further analysis of the Sec system in Mycobacteria showed that when 
secA2 in M. tb is deleted, the bacteria are highly attenuated in virulence 
suggesting that SecA2 may be responsible for exporting virulence factors (39) 
This M. tuberculosis ∆secA2 strain shows enhanced priming of CD+ T cells in 
vivo, is pro-apoptotic and combined with a defect for lysine auxotrophy (M. 
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tuberculosis ∆secA2∆lysA), the strain is a promising vaccine as it shows better 
protection and is safer than the traditional Bacillé Calmette- Guerin (BCG) 
vaccine (94,95). One strategy employed by M. tb to survive in host macrophages 
is the prevention of phagosome acidification by arresting the formation of 
phagolysosomes. After infection of macrophages with the M. tuberculosis 
∆secA2 strain, phagosomes were more acidified suggesting that SecA2 is 
important for secretion of factors that play a role in phagosome maturation arrest 
and promotes the growth of M. tb in host macrophages (96).  
M. tb SecA2 has been shown to be important for the export of Fe-
dependent superoxide dismutase A (SodA), a protein that lacks a typical Sec 
signal sequence (39). The SodA enzyme functions to remove reactive oxygen 
intermediates (ROI) so it is believed that perhaps export of SodA by M tb. SecA2 
is a strategy devised by the bacterium to counteract the oxidative burst by the 
host macrophages. Similar results are seen in Listeria monocytogenes, where 
Mn-SodA is secreted in a SecA2-dependent manner, however secreted SodA is 
differentiated from cytosolic SodA by phosphorylation (57). Secreted SodA is  not 
phosphorylated while cytosolic SodA phosphorylated. In Mycobacterium 
smegmatis, two predicted sugar-binding lipoproteins (1704 and 1712) that have 
typical Sec signal sequences were shown to require SecA2 for export (40). In L. 
monocytogenes, four predicted lipoproteins were identified, one of them 
belonging to the same class as M. smegmatis 1704 and 1712 (56). 
Biochemical studies have shown that both M. tb SecA1 and SecA2 are 
ATPases and are expressed at equal levels in the cell (43). Both proteins bind 
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ATP with high affinity and hydrolyze the nucleotide in a manner similar to E. coli 
SecA (43). Additionally, a Walker box variant of SecA2 that cannot bind ATP is 
unable to complement a M. tb ∆secA2 strain for growth in macrophages. The M. 
tb ∆secA2 strain could only be rescued when complemented with wild-type 
secA2 on a plasmid confirming that the ATPase activity of SecA2 is required for 
the growth of M. tb in macrophages (43).  
ATP binding is required for SecA2-dependent export even in M. 
smegmatis as a strain containing the corresponding Walker box mutation in 
SecA2, M. smegmatis secA2 K129R could not export 1704 and 1712 pre-
proteins (97). A M. smegmatis ∆secA2 strain shows defective growth on rich 
agar and shows increased sensitivity to azide. Not only is the M. smegmatis 
secA2 K129R strain unable to complement the defects associated with M. 
smegmatis ∆secA2, but also exacerbates the M. smegmatis ∆secA2 phenotype, 
characteristic of a dominant-negative phenotype (97). Based on quantitative 
immunoblot analysis of subcellular fractions, M. smegmatis SecA1 is equally 
distributed between the membrane and the cytosol, while SecA2 is only localized 
to the cytosol. The SecA2 K129R protein however, shifts localization to the 
membrane suggesting that the dominant negative phenotype may be due to the 
inactive SecA2 mutant trapped at the SecY translocon (97). Similar results were 
seen in Clostridium difficile when a Walker box mutant of SecA2 (SecA2 K106R) 
was generated. 
M. smegmatis secA2 K129R phenotypes have been shown to be 
associated with decreased SecY levels. Suppressor analysis led to the 
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identification of two extragenic suppressors that mapped to the secY protomoter 
region (98). These suppressors were found to increase secY transcription and 
consequent expression levels. Further, these suppressors alleviated the M. 
smegmatis secA2 K129R phenotype. Other suppressors associated with 
increasing SecY expression levels were identified, but those suppressors did not 
map to regions within the secY gene. Together these results show that the 
defects associated with the M. smegmatis secA2 K129R phenotype are due to 
improper functioning of SecY either due to degradation of SecY or an inactive 
translocation complex, perhaps due to jamming of the translocon (98). 
Additionally, these results highlight the fact that Mycobacterial SecA2 likely 
functions with the conventional SecYEG translocon, as opposed to another 
channel like SecA2 in bacteria with SecA2/Y2 systems. 
Since post-translational modifications seem important for directing export 
to the accessory Sec systems in SecA2/Y2 containing bacteria, it seemed likely 
that such modifications might play a role in SecA2 export in Mycobaceria, 
especially since SecA2-dependent precursors Msmeg1712 and Msmeg1704 
have lipobox motifs. However; it was found that the signal sequence of 
precursors is not required for SecA2-directed export suggesting that SecA2 must 
recognize a feature of the mature chain of the pre-protein. Also since the signal 
sequence contains the lipobox motif, mutation of the lipobox still rendered the 
pre-proteins SecA2-dependent verifying that lipid modification is not a pre-
requisite for SecA2 export (99). Using a SecA1 depletion strain of M. smegmatis, 
it was also shown that neither SecA1 nor SecA2 can solely export Msmeg 1712, 
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suggesting that SecA2 does require SecA1 for exporting pre-proteins (97).   
E. Structure of M. tuberculosis SecA1 
The M. tb SecA1 was crystallized in apo form (PDB ID 1NL3) with a 
resolution of 2.8 Å and the protein in complex with Mg2+:ADP-β-S (PDB ID 1NKT) 
was crystalized at 2.6 Å (100). The protein crystallized as an antiparallel dimer, 
although cryo electron microscopy (EM) reconstructions done under conditions 
similar to those used in crystallization revealed a SecA1 tetramer. The overall 
domain organization of SecA1 seems similar to SecA proteins from other 
bacteria (Figure 1-5). The protein consists of two motor domains encompassing 
residues 2-221 and 360-589 (NBD1 and NBD2 respectively). Nucleotide is bound 
between these two domains. The protein also contains a probable pre-protein 
binding domain (PPXD or PBD) called the substrate specificity domain (SSD) 
and helical core domain (HCD) also called IRA1 in other SecA proteins. A long 
helix joins NBD2 to the HCD. The structure with bound nucleotide overlays well 
with the apo form of the structure, except for a few amino acid residues directly 
involved in nucleotide binding indicating no major conformational changes are 
caused by ADP binding to SecA1. The residues involved in forming dimer 
contacts in the crystal structure are highly conserved and hydrophobic in nature. 
Recently however, a bioinformatics program called EPPIC that identifies 
biologically relevant protein-protein contacts revealed a new dimer interface in M. 
tb SecA1 (PDB ID 1NL3 ) that is related to the B. subtilis SecA (PDB ID 1M6N) 
dimer interface. The new contacts would involve contacts between the extreme 
N-terminus of one protomer of SecA1 and C-terminal residues of the IRA1 region, 
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SD and HWD of the other protomer. These contacts at the interface involve both 
hydrophobic and electrostatic interactions. 
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Figure 1-5: Structure of M. tuberculosis SecA1 
 
 
The structure of the M. tb SecA1 dimer (1 NKT) (100), represented by du Plessis 
et al. in a review article (101) is shown. One protomer of SecA is colored to show 
the different domains; nucleotide binding domains 1 (NBD1) and 2 (NBD2) in 
dark and light blue respectively, pre-protein binding domain (PPXD) in red , 
helical scaffold domain (HSD) in green and the helical wing domain (HWD) in 
yellow while the second promoter arranged in anti parallel fashion is shown in 
beige. The positions of the extreme amino (N) and carboxyl (C) termini are 
shown. The intra-molecular regulator of ATPase region (IRA1) is shown with an 
arrow. The orientation of the two protomers in the structure gives rise to a central 
opening between the protomers. This opening is thought to be aligned with the 
opening of the channel SecY. 
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F. Domain organization of M. tuberculosis SecA2 
 
M. tuberculosis SecA2 (86 kDa) is smaller compared to  its SecA1 
homolog (106 kDa) owing to a large truncation of its C-terminal domain (Figure 1-
6). Even though this is a common feature among SecA2 proteins, M. tb SecA2 
also has a deletion of around 35 amino acid residues between ATP binding 
motifs V and VI in NBD2 as well as deletions in the helical wing domain. 
Based on amino acid sequence alignment, SecA2 only shares thirty-three 
percent sequence identity to SecA1 (Figure 1-7). The highest conservation lies in 
the nucleotide-binding domains, particularly among residues directly involved in 
nucleotide binding and hydrolysis. Like SecA1, SecA2 also contains Walker A 
and Walker B motifs that have been shown to be important for ATP binding. In 
fact, SecA2 has a higher affinity for ATP (Kd ~1.9 µM) than SecA1 (Kd ~21 µM) 
and the ATPase activity of SecA2 is essential for the survival of the bacteria in 
host macrophages (43).  Substitution of the conserved lysine for arginine 
(K115R) or alanine (K115A) significantly reduces the ability of SecA2 to bind ATP 
in vitro (43).  
The greatest variation between the two proteins lies in the C-terminal 
domain. To date, there is no structural information on any SecA2 protein. 
However, from analysis of the amino acid sequence, the M. tb SecA2 protein like 
SecA1 and  conventional SecA proteins is a member of the superfamily 2 DEAD 
(DExH/D) proteins that include DNA and RNA helicases suggesting that the 
motor domains of SecA2 would be structurally similar to that of SecA1.  
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Figure 1-6: Comparison of domain organization of SecA2 proteins.   
 
 
This figure taken from Bensing et al. (50) compares domain organization of 
SecA2 proteins and with their corresponding SecA1 homolog as well as with 
SecA proteins from other bacteria containing an accessory SecA protein. The 
numbers below represent percent similarity/identity to the corresponding SecA 
homolog. 
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Figure 1-7: Alignment of amino acid sequences of M. tb SecA1 and SecA2 
by PRALINE (102).   
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G. Purpose of this study 
 Since several Gram-positive bacteria, many of which are pathogens such 
as M. tuberculosis have two SecA proteins, several important questions are 
raised regarding the role and significance of the additional SecA protein. In M. 
tuberculosis, SecA2 is thought to play an important role in virulence by exporting 
virulence factors like superoxide dismutase (SodA) helping the bacterium to 
combat the oxidative burst in the host macrophage (39). SecA2 has also been 
implicated in arresting phagosome maturation, a critical survival strategy 
employed by M. tuberculosis in host macrophages (96). As deletion of the secA2 
gene highly attenuates M. tuberculosis, this strain has been further modified and 
is a promising vaccine candidate against TB (95). Since there is no mammalian 
SecA homolog, the SecA proteins are also attractive drug targets. However, the 
the main role of this protein and its mechanism of action is unknown. Despite 
high sequence similarity between the two SecA proteins, the components of the 
secretion machinery are able to distinguish them. Since SecA2 is required for 
exporting only a subset of proteins some of which have typical signal sequences 
and some of which do not (Table 1-1), certain features of the precursor nascent 
chain must dictate SecA2 dependence.  
 This biochemical study explores the atypical features of SecA2 with 
respect to nucleotide-binding kinetics and membrane association in an attempt to 
decipher why some bacteria may require an additional SecA proteins and how 
the secretion machinery may distinguish the two SecA proteins. The study helps 
to elucidate the role of SecA2 in secretion and its importance in virulence.  
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Chapter 2 
METHODS 
 
A. Molecular Biology and Cloning 
 
 All molecular biology work, restriction enzymes, polymerases, ligase and 
kinase enzymes were purchased from New England Biolabs (NEB) and pET 
vectors were purchased from Novagen unless specified otherwise. High fidelity 
versions of all restriction enzymes were used if available from NEB. Primers were 
synthesized by Integrated DNA technologies (IDT) and the sequence of 
constructs made was verified by Genewiz. Sterile distilled water was used in all 
reactions. Autoclaved PCR tubes were used for all reactions and micropipettors 
and bench surfaces were wiped with bleach to prevent DNA contamination and 
remove nucleases. 
In order to make constructs for the expression of M. tb SecA1 and SecA2 
proteins secA1 and secA2 genes were amplified from M. tuberculosis genomic 
DNA (a gift from Miriam Braunstein). The secA1 gene was inserted between 
EcoRV and HindIII sites of a pET30b vector. In order to bring the gene closer to 
the ribosome binding site, the construct was further digested with Nde I and Nco I. 
Blunt ends were generated using the Klenow enzyme and ligated to put the 
secA1 gene between NdeI and HindIII of pET30b resulting in pND1. The SecA1 
protein is expressed with the sequence ‘MAM’ before the starting valine residue, 
coded for by a GTG start codon. Between the SecA1 protein and C-terminal His6 
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tag, the vector-derived sequence KLAAALE is present. It is important to note that 
due to blunting of the ends, the NdeI site is disrupted in the final construct pND1. 
In case of the SecA2 expression vector (pND2), the secA2 gene was directly 
inserted between NdeI and HindIII of pET30b. The stop codon before the His6 
tag was not removed when cloning, but was later modified by site directed 
mutagenesis to generate a construct pND2, in which SecA2 is expressed with a 
C-terminal His6 tag. In case of secA2 in the M. tb chromosome, the start site 
used is a GTG start site located at nucleotide position 91 from the annotated start 
site (NCBI accession number NP_216337) since this site represents the true 
start site (43). In pND2, An ATG start codon that codes for methionine was 
added before the GTG codon to ensure expression in E. coli. This construct also 
has the vector derived sequence KLAAALE between the protein and the C-
terminal His6 tag. 
PCR Amplification of DNA 
  In order to generate the constructs pND1 and pND2, a 50 µl PCR reaction 
was used for amplification of secA1 and secA2 genes from genomic DNA. 1 µl of 
a 1:50 diluted stock of genomic DNA was used as template. Phusion master mix 
containing high GC buffer was used. Phusion is a high fidelity polymerase and 
binds to the template much more tightly than other polymerases available. Such 
a polymerase is required for amplification of genes from DNA that has a high GC 
content. Primers for amplification of the secA1 and secA2 genes were designed 
to incorporate the restriction enzyme sites flanking the gene. 6.25 µl of a 4µM 
stock of each primer was added to the reaction. DMSO at a final concentration of 
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5 % was added to facilitate separation of the DNA template strands. Sterile 
nuclease free water was added to a final volume of 50 µl. 
For the PCR reaction, the initial denaturation was carried out for one cycle 
at 98 ºC for 30 seconds (step 1), followed by 30 cycles of denaturation at 98 ºC 
for 10 seconds, annealing for 30 seconds (annealing temperature was set using 
the online NEB Tm calculator that is specific for the DNA composition, 
concentration of primer, type of polymerase and buffer in the master mix) and 
extension at 72 ºC for 3 minutes (1 Kb of fragment/minute) (step 2). The final 
extension was carried out for one cycle at 72 ºC for 7 minutes (step 3) and the 
sample was held at 4ºC until further processed.  
Restriction Digestion 
The amplified product was verified by running 8 µl of the PCR product 
mixed with 2 µl of sample buffer on a 0.8 % agarose gel with SYBR safe 
(Invitrogen) incorporated into the gel, run at 100 V in 1X TAE buffer at pH 8.0 (40 
mM Tris, 20 mM acetic acid and 1 mM EDTA). Once the presence of a broad 
band was detected, the PCR products were purified using the PCR purification kit 
(Qiagen). Later on, the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel) 
was used routinely as it gave a much higher yield of product. DNA was eluted in 
30 µls of water. Vector DNA was prepared by doing a plasmid prep from 4 mL of 
an overnight culture of E. coli DH5α cells using the StrataPrep plasmid mini prep 
kit (Agilent) and eluting the plasmid in 30 µl of water. Generally, this resulted in a 
yield of about 2-5 µg of insert and vector DNA. For cloning purposes, plasmid 
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vectors were always prepared fresh on the day of use, never from frozen stocks 
as freeze-thawing plasmids was found to make them unsuitable for restriction 
digestion resulting in smears on the gel instead of single bands. The insert and 
vector DNA were digested using 50 units of each restriction enzyme (2.5 µl of 
20,000 U/mL). This also ensured that the final glycerol concentration did not 
exceed 5% in a final volume of 50 µl, thus preventing star activity. The 
appropriate NEB buffer and BSA (when required) were added to a final 
concentration of 1X and water was used to bring the final volume to 50 µl. When 
the two restriction enzymes were not compatible for double digestion, single 
digestions were performed sequentially; however this was very rare. The 
restriction digestion was performed at 37 ºC for 2 hours.  DNA sample loading 
buffer (6µl) was added directly to the digestion products and they were separated 
on a 0.8 % agarose gel with SYBR safe, run at 100 V (described earlier) until the 
bands were well separated. Bands of the digested vector and insert 
corresponding to the correct molecular weight were cut out from the gel using a 
razor blade, transferred to a microfuge tube and weighed. DNA was extracted 
from the gel bands using the Qiaquick gel extraction kit (Qiagen). For a 0.8 % gel, 
240 µl of buffer QG was added to 100 mg of gel followed by incubation at 50 ºC 
for 10 minutes (until the agarose was dissolved). One gel volume of isopropanol 
was added to the sample, mixed and transferred to a spin column that was 
centrifuged for 1 minute in a microfuge at maximum speed. This was followed by 
washes in 500 µl buffer QG and 750 µl buffer PE. After this the spin column was 
spun without any buffer at maximum speed for a minute to remove any residual 
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buffer. DNA was eluted in 30 µl of water. This process of gel extraction was 
found to be effective but resulted in a significant loss of DNA so this step was 
later modified to exclude gel extraction and PCR purification was performed 
instead to purify the digested products. In order to do this, verification of 
complete digestion (observed on a gel) is crucial. Once it was established that 
complete digestion was obtained, 30 µl of the digestion reaction was purified 
using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel). The products 
were eluted in 20 µl of NE buffer from the kit.  
Treatement with Klenow 
In cases where a region of the plasmid had to be cut, or if the restriction 
sites in the multiple cloning region of the vector could not be used to incorporate 
the insert, blunt ended cloning was performed using the large fragment of DNA 
polymerase I, commonly known as the Klenow fragment. This enzyme fills in 5’ 
overhangs or removes 3’ overhangs generating blunt ends.  After digestion of the 
vector or insert or both, NEB buffer 2 was added to a final concentration of 1X, 
directly to 30 µl (or 20 µl) of the purified digestion products. To this mixture, 50 
µM (final concentration) of dNTPs and 0.5 µl of Klenow were added and 
incubated at room temperature for 20 minutes. This was followed by the addition 
of 0.5 µl of 0.5 M EDTA and the reaction was heated at 75 ºC for 20 minutes to 
inactivate the enzyme. 
Dephosphorylation of Vector 
This step is required to prevent the vector from re-ligating without the 
 38
incorporation of the insert. It is mandatory when restriction digestion yields blunt 
ended products, but is recommended even for vectors with sticky ends, to 
prevent re-ligation of the vector population that was cut with only one restriction 
enzyme. The enzyme Antarctic phosphatase (AP) was used for 
dephosphorylation instead of shrimp alkaline phosphatase (SAP) or calf intestinal 
phosphatase (CIP) as unlike AP, the products of CIP and SAP reactions require 
PCR purification to remove the phosphatase before ligation. AP can be 
inactivated by heat and no further purification of the reaction is required before 
ligation. For the reaction, 1 µl AP was added to 20 (or 30 µl) of digested and 
purified vector DNA (or directly to the inactivated Klenow reaction). Antarctic 
phosphatase buffer was added to a final concentration of 1X. The reaction was 
incubated at 37 ºC for 15 minutes, followed by heat inactivation of the enzyme at 
65 ºC for 5 minutes. The dephosphorylated vector was then directly used in the 
ligation reaction. 
Ligation 
Several vector:insert ratios were tested. Ultimately, after several 
experiences with cloning according to this protocol, 1-2 µl of vector mixed with 5-
10 µl of insert in a final volume of 20 µl always resulted in successful ligation. 
Ligation buffer (final concentration 1X) and 1 µl of T4 ligase was added. 
Incubation was performed at room temperature for 1 hour. For this, the rapid 
ligation kit (Fermentas) or T4 ligase at 2,000,000 U/mL (NEB) should be used. 
Use of T4 ligase solutions at lower concentrations required significantly longer 
incubation times. Control reactions were always set up that did not contained 
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only the dephosphorylated vector (no insert) and ligase as well as 
dephosphorylated vector (no insert) without ligase. 
Note that it was difficult to estimate the concentrations of vector (and 
calculate amount of vector) since the dephosphorylation buffer contains a high 
ATP, which absorbed significantly at 260 nm. However to calculate the 
vector:insert, the following formula can be used: 
 
                                Amount of Insert (ng) = 50ng vector * size of insert (kbp) 
                                                     size of vector (kbp) 
 
Use of a unique cutter  
Once the ligation reaction was completed, the ligase enzyme was 
inactivated by heating the reactions at 65 ºC for 10 minutes and then cooled to 
room temperature. To this reaction, 1 µl of a restriction enzyme was added 
followed by incubation at 37 ºC for 30 minutes. A restriction site in the multiple 
cloning region of the vector was picked that would have actually been occupied 
by the insert. By targeting this site, only vectors that took up the insert would not 
be affected and remain intact. Care should be taken that the insert itself does not 
have restriction sites for this particular restriction enzyme and that this enzyme is 
a unique cutter in the vector.  
Transformation 
After digestion, the entire reaction was added to 50 µl of competent E. coli 
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DH5α cells on ice for 30 minutes. Heat shock treatment was carried out at 45 ºC 
for 45 seconds followed by recovery on ice for 3 minutes. 500 µl of SOC medium 
was directly added to the cells and incubated on a nutator at 37 ºC for 1 hour. 
The cells were spun down. The pellet was carefully resuspended in ~ 50 µl of 
SOC medium and the entire volume was plated on LB agar plates containing the 
appropriate antibiotic and incubated overnight at 37 ºC. 
Screening of correct ligation products by colony PCR. 
The colonies on plate were screened to check for ones that possessed the 
plasmids with the correct insert incorporated. The primers chosen for colony PCR 
were such that one primer would bind to the vector (such as T7 forward primer) 
and the other would bind to the insert (such as the reverse primer used to amplify 
the insert from template in the first step of the cloning procedure). This ensures 
that amplification only occurs when the insert is in the vector and decreases 
chances of false positive results due to amplification of insert that may be on the 
agar plate (due to the ligation mixture added to cells which get plated). For 
colony PCR, a micropipette tip was touched to a colony on the plate and then 
inserted into a tube containing the PCR reaction mixture (PCR reaction mixture 
described earlier, however to conserve the master mix, the reaction was reduced 
to a 25 µl volume reaction, instead of a 50 µl reaction). The same tip was then 
used to make a streak in one sector of an LB/antibiotic plate that was divided into 
several sectors. The streak from the colony was numbered according to the 
corresponding PCR tube it was inserted into. After this was repeated for several 
colonies, the plate was incubated at 37 ºC overnight. The tubes containing the 
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PCR reaction mixtures were subjected to PCR using the conditions described in 
the first part of this chapter. 10 µl of each PCR reaction were taken and added to 
2 µl of sample loading buffer. 10 µl were loaded on a 0.8 % agarose gel and run 
as described earlier. Samples that showed amplification of the correct sized 
insert indicated successfully ligated products. Once the positive reactions were 
identified, the corresponding bacterial streak was used to inoculate 5 mL of 
LB/antibiotic. The cultures were grown overnight with aeration at 30 ºC. Plasmid 
was extracted from 4mL of the overnight culture using the StrataPrep kit (Agilent) 
and the presence of the insert was verified by sequencing (Genewiz). 
Site Directed Mutagenesis 
Site directed mutagenesis of amino acid residues was achieved using the 
staggered primer method (103). This method was used to decrease the chances 
of primer dimerization while increasing the chances of annealing the primer to the 
template. Following this method of primer design, 6-8 non-overlapping bases 
were added to the 3’ end of each primer. The targeted mutation was introduced 
in both primers and both primers had a G or C base at each end. PCR was 
carried out in a total volume of 50 µl and the conditions for PCR were similar to 
those described earlier in this chapter, however instead of genomic DNA, 1 µl of 
10 ng/µl plasmid DNA was used as template and DMSO was excluded from the 
reaction. Also Step 2 was reduced to 16 cycles instead of 30. After amplification, 
5 µl of NEB buffer 4 and 2 µl of DpnI were directly added to the 50 µl reaction 
and incubated at 37 ºC for 2 hours. 10-20 µl was then transformed into E. coli 
DH5α cells by the heat shock method described earlier.  
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Example of primer design for a GA substitution: 
The template strands are represented in italics while the primers are 
represented in bold letters. The base to be changed in shown in red. The arrows 
represent the direction in which the primers would advance. 
Orginal sequence: 5’ tcctgaagtgcgaagcttggggccgcataatgcta  3’ 
5’ tcctgaagtgcgaagcttgaggccgcataatgcta  3’ 
      3’<< cacgcttcgaactccggcg  5” 
 
                                5’            agcttgaggccgcataatg >>  
3’    aggacttcacgcttcgaactccggcgtattacgat  5’  
 
Primer 1: 5’ agcttgaggccgcataatg 3’ 
Primer 2: 3’ gcggcctcaagcttcgcac 5’ 
 
Insertion or deletion of residues by PCR 
 
Insertion or deletion of several bases was done by designing primers that 
either had the bases to be incorporated (in case of insertion) or excluded a 
region of the template (in case of deletion). In case the insertion was fairly large, 
the inserted segment was split between the forward and reverse primer. 
Examples of such primers are shown below. The template strands are 
represented in italics while the primers are represented in bold letters. The bases 
to be inserted or deleted are shown in blue. The arrows represent the direction in 
which the primers would advance. 
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Example1: Insertion of FLAG tag (in blue) at N-termimus of SecY in pBAD24. 
5’ 
atggatatcgattacaaggatgacgacgataaggtgctgtctgcctttattag 3’   
          3’ <<<gctgctattccacgacagac 5’ 
5’ atggatatcgattacaaggatga>>> 3’ 
3’ 
tacctatagctaatgttcctactgctgctattccacgacagacggaaataatc 5’ 
 
Forward primer: 5’ atggatatcgattacaaggatga 3’ 
Reverse primer: 5’ cagacagcaccttatcgtcg 3’ 
 
Example 2: Deletion of DEAD box 3 in SecA2. 
 
5’ 
cgacatcaggctcggcgggtccgacgaagctgaccacgacagggtcgcggaat 3’ 
  <<<tgtagtccgagccgcccagg 5’  
                                  5’
 cacgacagggtcgcggaat>>> 
3’ 
gctgtagtccgagccgcccaggctgcttcgactggtgctgtcccagcgcctta 5’ 
 
Forward primer: 5’ cacgacagggtcgcggaat 3’ 
Reverse primer: 5’ ggacccgccgagcctgatgt 3’ 
 
 
The PCR conditions used for amplification were the same as those 
described earlier in this chapter, except 1 µl of 10 ng/µl plasmid DNA was used 
as template. 10 µl of the PCR reaction was then mixed with 2 µl of DNA gel 
loading buffer and 10 µl was subjected to agarose gel electrophoresis in a 
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manner described earlier. Once it was verified that the product had been 
amplified, the product was phosphorylated as follows: 4 µl of the PCR product 
was added to 5 µl of 10X Ligation buffer. 1 µl of T4 polynucleotide kinase was 
added and the volume was brought up to 50 µl with sterile distilled water. The 
phosphorylation reaction was incubated at 37 ºC for 30 minutes. The kinase was 
then inactivated by heating at 65 ºC for 5 minutes and cooled to room 
temperature. To 4 µl of the phosphorylated product, 2 µl of 10X ligation buffer 
and 1 µl T4 ligase (2,000,000 U/ mL) was added and the reaction volume was 
brought up to 20 µl with sterile distilled water. The ligation reaction was incubated 
at room temperature for 1 hour followed by transformation of the entire reaction 
into into E. coli DH5α cells by the heat shock method described earlier. 200 µl of 
the transformed cells were plated on LB/antibiotic plates and incubated at 37 ºC 
overnight till colonies developed. 
B. Protein Expression and Purification 
The respective plasmids were transformed into E. coli 
Rosetta2(DE3)pLysS competent cells (Novagen) for expression. Expression 
tests were carried out by inoculating 5 mL LB/antibiotic with a colony, incubated 
overnight at 37 ºC with aeration. In a similar way, several colonies were 
inoculated separately in LB broth. A 1:100 dilution of the overnight culture was 
done in fresh LB/antibiotic and grown to O.D600 ~ 0.5. Day cultures were induced 
with 0.5 mM isopropyl-β-D-thiogalactopyranoside (IPTG) and grown further for 4 
hours. Before induction and 4 hours after induction, 0.2 O.D*mL were taken and 
spun down at maximum speed in a microfuge. The pellets were resuspended in 
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3X SDS sample buffer and 10 µl was loaded on a 10 % SDS gel, run at 200 V 
and stained with Coomassie blue. The culture that showed the best induction 
was chosen for growth on a large scale. The large scale culture (3L) was grown 
in a similar manner as the ones tested for induction and harvested 4 hours after 
induction by centrifuging at 4000 rpm (35000 x g) in an SLC 6000 rotor (Sorvall). 
All purification steps were carried out at 4 ºC. Cell pellets were suspended in 
Wash 1 buffer (10 mM imidazole pH 8.0, 20 mM Na2HPO4, 300 mM NaCl) 
containing 1X protease inhibitor cocktail (Sigma) or 1X Complete mini EDTA-free 
cocktail (Roche) and frozen at -80 ºC. Cells were thawed on ice followed by the 
addition of 1X protease inhibitor cocktail, 450 µg/mL each of DNase and RNase 
and 10 mM MgCl2 (final concentrations). When the cell density was high and total 
volume of resuspended cells was ~25 mL, cells were lysed with a French 
pressure cell (SLM-Aminco) at 20,000 lb/in2. If the cell density was low, cells 
were lysed by sonication on ice, using a regular probe on the sonicator (Misonix). 
The amplitude was set to 35. The pulse was set to remain on for 15 seconds and 
off for 30 seconds, for a total of 2 minutes of ‘on’ time. The lysates were 
centrifuged at 15,000 rpm (32,000 x g) in an F18S-12X50 fixed angle rotor 
(Sorvall) for 15 minutes to sediment broken cells, followed by ultracentrifugation 
at 40,000 rpm  (162,000 x g ) in a T-865 rotor (Sorvall) for 1 hour to spin out the 
membranes.  
Metal affinity chromatography 
The clarified lysate (supernatant from the ultracentrifugation spin) was 
applied to a 10 mL column with Talon Superflow metal affinity resin (Clontech) at 
 46
1 mL/min. Unbound protein was eluted with six column volumes of Wash 1 buffer. 
The His6 tagged proteins were eluted with six column volumes of 250 mM 
imidazole pH 8.0, 20 mM Na2HPO4, 300 mM NaCl. The flow rate was maintained 
at 1 mL/min throughout the run and 1.5 mL fractions were collected during the 
elution step.  
SDS PAGE of column fractions 
To analyze the fractions by SDS-PAGE, 20 µl of a fraction was added to 
10 µl of SDS sample buffer and 10 µl was loaded onto a 10% SDS gel. The gel 
was run at 200 V and stained with Coomassie blue to visualize the bands. 
Concentration of protein by ammonium sulfate precipitation or 
concentration device 
When the volume of protein to be concentrated was large, fractions 
containing pure protein were pooled and concentrated by ammonium sulfate 
precipitation at 60 % saturation. To do this, 36.1 g of solid ammonium sulfate was 
added per 100 mL of protein solution, stirring slowly at 4 ºC for approximately 
one hour. The solution was centrifuged at 15,000 rpm (32,000 x g) in an F18S-
12X50 fixed angle rotor for 20 minutes. The pellet was resuspended in 0.5-1 mL 
of dialysis buffer and then dialyzed against one liter of 10 mM 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), pH 7.6 in a dialysis bag with a 
molecular weight cut-off of 10,000 kDa, overnight at 4 ºC. After this, the buffer 
was changed twice while dialysis was allowed to proceed for three hours in 1 L of 
buffer each time.  
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In case the total volume of pooled protein was around or below 30 mL, an 
Amicon centrifugal filter device (Millipore) with the appropriate molecular weight 
cut-off filter was used for concentration. The filter device was rinsed with water to 
remove glycerol from the membranes before use. The device containing pooled 
protein was then centrifuged at 4,000 x g in a swinging bucket rotor at 10 minute 
intervals. The protein concentration was checked each time and when the 
desired concentration was achieved the protein was dialyzed as described earlier. 
Once buffer exchange was achieved, aliquots of pure protein were made, frozen 
at -80ºC and were never refrozen once thawed. 
Removal of bound nucleotide by Blue Sepharose chromatography 
Blue Sepharose (GE Healthcare) chromatography was used to separate 
the nucleotide-bound form of SecA2 from the nucleotide-free form. After 
purification using the Talon column, SecA2-(His)6 was dialyzed into 25 mM Tris 
pH 7.6 buffer instead of HEPES buffer. The dialyzed protein was loaded onto a 
10 mL Blue Sepharose column, washed with 25 mM Tris pH 7.6 for 2.5 column 
volumes. Nucleotide-free SecA2 was then eluted over 6 column volumes with 2 
M NaCl. Fractions of 1.5 mL were collected throughout the run, and also during 
the wash steps. The flow rate was maintained at 1 mL/min during the entire run. 
The protein content of the fractions was analyzed by SDS PAGE as described 
earlier. Fractions containing nucleotide-free SecA2 were pooled, dialyzed against 
10 mM HEPES pH 7.6, 25 mM KCl and stored as aliquots at -80 ºC. 
 
 48
Size Exclusion Chromatography 
Purified SecA proteins were characterized by size exclusion 
chromatography using a BioLogic Duo-Flow system (Bio-Rad). Protein (250 µl) 
was applied at ~ 20 mg/mL to a Superdex 200 10/300 GL column (GE 
Healthcare), and eluted at 0.25 mL/min in either low salt buffer (10 mM HEPES, 
pH 7.6, 25 mM KCl, 1 mM MgCl2, 0.1 mM Tris  (2-carboxyethyl)phosphine 
(TCEP-HCl) (Pierce)) or high salt buffer (10 mM HEPES, pH 7.6, 300 mM KCl, 1 
mM MgCl2, 0.1 mM TCEP-HCl). Ultrapure ATP or ADP (Sigma) was added to the 
buffer at a final concentration of 1 mM for chromatography with nucleotide. The 
UV absorbance was recorded at 280 nm. The molecular weight was estimated 
based on high molecular weight calibration standards ferritin, catalase, aldolase 
(GE Healthcare) and creatine phosphokinase that were run on the column under 
similar conditions to the SecA proteins. 
Ion (Anion) Exchange Chromatography  
Nucleotide-free or nucleotide-bound SecA2 was loaded onto a 1 mL Hi-
Trap Q column (GE Healthcare) in 25 mM Tris pH 7.6 using a BioLogic Duo-Flow 
system (Bio-Rad). The column was washed with 5 mL of 25 mM Tris pH 7.6. A 
linear gradient from no salt to 1.5 M NaCl in 25 mM Tris pH 7.6 was run over 25 
mL followed by 5 mL of 1.5 M NaCl. Fractions of 1.5 mL were collected 
throughout the run. Where required, nucleotide-free SecA2 was incubated with a 
ten-fold molar excess of ADP on ice for 30 minutes before being loaded onto the 
Hi-Trap Q column. 
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C. Agarose Gel Electrophoresis of proteins 
Protein agarose gel electrophoresis was carried out using 1% SeaKem 
HGT agarose (Lonza) in 40 mM Tris, 20 mM acetic acid pH 8.0 using a horizontal 
gel apparatus (BioRad). Samples were prepared at room temperature in low salt 
buffer with the final protein concentration at 6 µM monomer. Wherever necessary, 
nucleotides or nucleotide analogs were added to a final concentration of 0.5 mM. 
The samples were incubated for ~ 30 minutes at room temperature before the 
addition of native gel sample buffer. The gel was run at 100 V, followed by 
staining with Coomassie blue to visualize the bands.  
D. Fluorescence spectroscopy 
Nucleotide Binding Kinetics by fluorescence 
Kinetics of nucleotide binding and release were studied by fluorescence 
resonance energy transfer (FRET) between the tryptophans of SecA and N'–
methylanthraniloyl (MANT) nucleotides (Molecular Probes) in an Aminco 
Bowman Series 2 luminescence spectrometer. The excitation and emission 
monochromators were set to 295 nm and 450 nm, respectively, with 4 nm 
bandpasses. The sample chamber was maintained at 20 ºC. Varying 
concentrations of SecA from 0.05 µM to 0.5 µM were assessed, keeping the 
MANT nucleotide concentration in excess at 1.2 µM. Since there was no change 
in the kinetic constants for this SecA concentration range tested, further kinetic 
experiments were performed using 0.5 µM SecA to improve the fluorescence 
signal. The SecA protein was incubated in buffer (10 mM HEPES pH 7.6, 25 mM 
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KCl, 1mM MgCl2) in a 1 cm cuvette with stirring. After the addition of MANT 
nucleotide, the increase in MANT fluorescence was monitored with time. Once 
saturation was reached, 1 mM unlabeled nucleotide was used to compete the 
MANT nucleotide from the SecA proteins. The curves were fit to a first order rate 
equation to give the apparent rate constants for the association reaction (kobs) 
and reverse reaction (koff). The rate constant kon was calculated using the 
equation: 
kobs = kon [MANT nucleotide] + koff 
 
The dissociation constant (Kd) was calculated by dividing the koff by the kon 
(104,105).To verify pseudo-first order kinetics, the kobs was determined at varying 
MANT-ADP concentrations with the SecA proteins held at 0.5 µM. From the plots 
of kobs vs. MANT-ADP, the kinetics parameters kon and koff were obtained from 
the slope and y-intercept, respectively, when fitted by linear regression.  
Pyrene fluorescence studies  
In order to label the SecA proteins with N-(1-pyrene) iodoacetamide (Life 
Technologies) via cysteine residues, 0.5 µl of 0.1 M tris (2-carboxyethyl) 
phosphine TCEP-HCl pH 7.0 was added to 100 µl protein (~45 µM) for thirty 
minutes at room temperature, followed by the addition of 5 µl of 10 mM N-(1-
pyrene) iodoacetamide. The samples were incubated on a nutator at 4 ºC 
overnight. Unbound label was removed by the loading the samples on micro Bio-
Spin 6 column (BioRad), pre-washed with 10 mM HEPES buffer pH 7.6, 25 mM 
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KCl. The samples were eluted by centrifuging the column at 1000 x g for 1 min. 
The absorbance at 280 nm and 338 nm was read to determine the extent of 
labeling of the proteins. 
Pyrene emission scans of 0.5 µM labeled protein in 10 mM HEPES buffer 
pH 7.6, 300 mM KCl in a total volume of 300 µl, were taken using an Aminco 
Bowman Series 2 luminescence spectrometer. The excitation and emission 
monochromators were set to 338 nm and 375 nm, respectively; with 4 nm 
bandpasses at 25 ºC. Emission scans were performed from 350 to 600 nm. 
ACMA fluorescence assay to check membrane vesicle integrity  
2 µl of membrane vesicles (MVs) (preparation described later) were added 
to 1 mL of buffer (10 mM HEPES pH 7.6, 100 mM KCl, 5 mM MgCl2), stirring in a 
cuvette at 20 ºC. The excitation and emission wavelengths were set to 410 and 
480 nm respectively with 4 nm bandpasses. ACMA (9-amino-6-chloro-2-
methoxyacridine) (Molecular Probes) and CCCP (carbonyl cyanide m-
chlorophenyl hydrazine) (Sigma) were prepared in dimethyl sulfoxide (DMSO). 
ACMA was added to the MV solution in the cuvette at a final concentration of 2 
µM and the baseline was monitored for approximately 5 minutes. Substrate was 
added at a final concentration of 1 mM and the fluorescence signal was 
monitored with time. After no more quenching of ACMA fluorescence was 
observed, the uncoupler CCCP was added at a final concentration of 1 µM and 
the consequent increase in the ACMA signal was monitored.  
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E. Circular dichroism (CD) spectroscopy of proteins 
Thermal melts by CD spectroscopy 
Thermal melts were carried out in a 2 mm path length cuvette with an 
Applied Photophysics Pi-Star 180 circular dichroism (CD) spectropolarimeter. 
The protein concentration used was 0.1 mg/mL in 10 mM HEPES pH 7.6, 25 mM 
KCl buffer. Wherever necessary, nucleotide was added to the buffer at a final 
concentration of 0.5 mM. The temperature was increased using a circulating 
water bath and the CD signal at 222 nm was recorded with slits set to 2 nm. The 
step size was 0.5 ºC and the tolerance was set to 0.2 ºC. The data were 
averaged for 300,000 points and were normalized to show the fraction unfolded 
with temperature. 
CD spectra of proteins 
CD spectra were obtained using 100-200 µg/mL protein in 20 mM sodium 
phosphate buffer at pH 7.6 in a 1 or 2 mM path length cuvette at 20 ºC. Slits were 
set to 2 nm and scans were performed from 200 to 250 nm with a 1 nm step size 
with a  settling time of 12.5 seconds at each wavelength. 
F. Proteolysis Experiments 
Thrombin proteolysis of SecA2 
SecA2 (0.8 mg/mL) was digested with 0.08 U of biotinylated thrombin 
(Novagen) in the presence or absence of 2 mM ADP in 20 mM sodium 
phosphate buffer pH 7.6 supplemented with 1 mM MgCl2 at room temperature. 
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Aliquots in duplicate were taken at various times and added to SDS sample 
buffer. The digested products were separated by SDS PAGE. One set of 
samples on the gel was stained with Coomassie to visualize the bands while the 
second set was transferred to a PVDF membrane and stained with Coomassie 
blue. The membrane was destained with 100% methanol briefly to remove 
excessive background stain. Four proteolytic fragments were cut from the 
membrane and the sequence of the amino terminus of each fragment was 
determined using 4 cycles of automated Edman degradation (Tufts University 
Core facility). 
Limited proteolysis of SecA2 by Trypsin and V8 
For digestion, 9 µM SecA2 either with or without 1 mM ATP (or ADP) was 
incubated with 45 µM protease (Trypsin or V8) in 20 mM sodium phosphate 
buffer at pH 7.6 containing 1 mM MgCl2 at room temperature in a final volume of 
100 µl. Aliquots of 10 µl were taken at varying time points and added to 1µl of 1 
mg/mL bovine pancreatic trypsin inhibitor (BPTI) on ice for 15 min. After 
incubation, 10 µl of SDS sample buffer was added to each aliquot and 10 µl of 
the sample was separated on a 10 % SDS gel 
G. Growth of M. smegmatis and preparation of M. smegmatis membrane 
vesicles  
The M. smegmatis strain (LL099) used for the preparation of membrane 
vesicles (MVs) was a gift from Miriam Braunstein. This strain contains two secY 
genes. The first copy is that of native secY on the chromosome and the second 
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is that of secY expressed with a hemagglutinin (HA) tag on a plasmid that 
integrates into the tweety site. The plasmid that encodes for SecY confers 
resistance to hygromycin. The strain was streaked on a Mueller Hinton agar plate 
that contained 10 µg/mL cyclohexamide (CHX) (Sigma), 50 µg/mL ampicillin, 
0.05 % Tween 80 and 50 µg/mL hygromycin B (HYG) (Gold biotechnology). CHX 
was used to prevent the growth of mold and was prepared in ethanol. Ampicillin 
was used to prevent the growth of other bacteria, as Mycobacteria are naturally 
resistant to ampicillin due to the production of beta lactamases. Tween 80 was 
used to prevent clumping of Mycobacteria as a result of their mycolic acid-rich 
cell wall. The plate was incubated at 37 ºC until colonies appeared (3-4 days). A 
single colony from the plate was used to inoculate a 10 mL Erlenmeyer flask of 
sterile Mueller Hinton broth (Difco) containing the above components present in 
the plate at the same final concentration. Additionally, ~ 5 sterile glass beads 
were added to the culture to prevent clumping of mycobacteria while the culture 
was rotated on a shaker at 150 rpm at 37 ºC overnight. This culture was then 
used to inoculate a 2 L flask containing 500 mL of sterile Mueller Hinton medium 
(with all the additional components and sterile glass beads) to achieve an O.D600 
~ 0.02. This culture was grown at 37 ºC rotating at ~150 rpm to an O.D600 ~ 0.8-
1.0 and spun down in 150 mL volumes/bottle in a swinging bucket rotor (Sorvall) 
at 4000 rpm for 15 minutes. The pellets were frozen until further required.  
MVs were always prepared just before use and tested for configuration 
and seal using the ACMA fluorescence-quenching assay before use.  For 
preparation of MVs, one tablet of complete protease inhibitor cocktail (Roche) 
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was resupended in 0.5 mL distilled water and added to the frozen pellet. The 
pellet was thawed and resuspended in a minimum volume of 50 mM, MOPS-
KOH (pH 7.5) 2mM MgCl2. 1500 units of DNAse and 15 mM MgCl2 were added 
to the cells.  The cells (~2mL in volume) were lysed using a sonicator (Misonix) 
fitted with a micro tip. The cells were kept on ice during sonication. The amplitude 
was set to 35 and the pulse was set to remain on for 15 seconds, off for 30 
seconds, for a total of 2 minutes of ‘on’ time. The broken cells were pelleted in a 
microfuge at maximum speed for 5 minutes. The supernatant was subjected to 
centrifugation at 60,000 rpm (163,000 X g) in 1 mL tubes using a S120AT2 rotor 
at maximum acceleration and deceleration. The brown pellet containing MVs was 
resuspended in 50 mM MOPS-KOH (pH 7.5), 2mM MgCl2.  
When endogenous SecA had to be stripped from the membranes, the 
brown pellet was resuspended in 1 mL of 6 M urea made in MOPS buffer (above) 
and allowed to stand for 30 minutes at room temperature. This was followed by 
centrifugation at 75,000 rpm as done above. The pellet was resuspended in 1 mL 
of MOPS buffer and centrifuged again to remove any residual urea. The pellet 
from this spin was then resuspended in ~ 100 µl of MOPS buffer and used for 
experiments.  
H. Membrane floatation assay using OptiPrep gradients 
A working solution (WS) of 50 % iodixanol (OptiPrep) was prepared by 
mixing 5 mL of 60 % (w/v) OptiPrep (Sigma) having density 1.32 g/mL with 1 mL 
of diluent (120 mM HEPES-KOH, pH 7.6, 30 mM MgCl2). A 35 % overlay was 
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further prepared by diluting the WS with diluent. Samples were prepared directly 
in centrifuge tubes in a final volume of 50 µl using 1 X buffer (10 mM HEPES-
KOH, pH 7.6, 10 mM KCl, 2 mM MgCl2). The final amount of SecA protein used 
in the gradient was 20 µg. The volume of MVs used was 25 µl. Wherever 
required nucleotide was added at a final concentration of 1 mM. The samples 
were allowed to incubate at room temperature for 30 mins before being mixed 
with 200 µl of the WS to make a 40 % solution. The solution was overlayed with 
750 µl of the 35 % solution. The 1 mL gradients were spun at at 4ºC at 100,000 
rpm for 1hr in the S120AT2 fixed angle rotor. The acceleration and deceleration 
were set to 5 and 1 respectively. Since the concentration of MVs could not be 
assessed and a fixed volume was used each time, only samples from the same 
run or vesicle preparation were compared with each other. 
For analysis of the gradients, 200 µl fractions were taken from the top 
using a positive displacement pipette. 20 µl of each of the fractions was further 
taken and mixed with 10 µl of 3X SDS sample buffer and 10 µl was used to run 
SDS PAGE followed by Western Blotting.  
I. Western Blotting 
The SDS gel was transferred to an Immobilon PSQ  PVDF membrane 
(Millipore) that was pre-incubated for a few minutes in methanol before transfer. 
The transfer was carried out using a mini Trans-Blot cell (BioRad) in 25 mM Tris, 
192 mM glycine pH 8.3, stirring at 30 V overnight or 100 V for 1 hour. A cooling 
pack was used to prevent over-heating of the buffer. The blot was blocked with 
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10 % powdered milk in 1X TBS (50 mM Tris, pH 7.6, 150 mM NaCl) for 30 
minutes on a shaking platform. The milk solution was filtered using a Whatmann 
filter paper to remove particulate casein prior to blocking. 4 µl of primary 
antibody; rabbit polyclonal biotinylated anti-His antibody (Genscript) was added 
to the blot in 10 mL of 1X TBS, 10 % milk. Incubation was carried out for 2 hours 
on a shaking platform. The blot was washed with distilled water, allowed to 
incubate for 5 minutes in 50 mL 1X TBS containing ~ 0.05 % Tween 20 and 
washed. The washing step was repeated 5 times followed by the addition of 5 µl 
of secondary antibody (Alexa-532 goat anti-rabbit antibody) or reagent 
(Streptavidin-Phycoerythrin conjugate) (Molecular Probes) in 10 mL of 1X TBS, 
10 % milk. Incubation was carried out as done before for 1 hour and 30 minutes 
followed by washing of the blot five times as done before. The blot was then 
visualized using a Typhoon scanner (GE Healthcare life sciences) using 
excitation and emission filters for Alexa-532 at 450 V or Personal Molecular 
Imager (BioRad). 
 J. Sedimentation Velocity Analytical Ultracentrifugation 
The peak of the pure SecA2 eluted in high salt buffer from the Superdex 
column was concentrated using an Amicon centrifugal filter device (Millipore) and 
used for sedimentation velocity analytical ultracentrifugation in a Beckman 
Coulter Optima XL-I centrifuge (University of Connecticut Analytical 
Ultracentrifugation Facility). Samples consisted of increasing concentrations of 
SecA1 and SecA2. The solvent compartment was loaded with the high salt buffer 
used to run the Superdex column. Samples were centrifuged with a Beckman 
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XL-I AU at 40,000 rpm at 20 °C and data were collected with interference optics. 
Data from sedimentation velocity runs were first analyzed with DCDT+ (106).The 
program Sedinterp was used to estimate the solvent density and partial specific 
volume of the protein (107).  
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Chapter 3* 
SECA2: A DIFFERENT KIND OF SECA PROTEIN 
*Parts of this chapter have been published.   
(D'Lima NG, Teschke CM, J Biol Chem. 2014;289(4):2307-17) 
Introduction 
According to the World Health Organization, approximately one third of the 
world’s population is infected with Mycobacterium tuberculosis, the causative 
agent of the disease Tuberculosis (TB). TB is the leading cause of death by a 
bacterial pathogen. In 2011 alone, it claimed the lives of 1.4 million people. 
Additionally, the emergence of multi-drug resistant (MDR) strains has caused 
worldwide concern. In 2011, of the 310,000 cases of MDR TB, nine percent had 
extensively drug resistant (XDR) TB. (World Health Organization fact sheet on 
“Tuberculosis” located online at: www.who.int/mediacentre/factsheets/fs104/en). 
Despite substantial efforts to forge effective countermeasures, the development 
of antibacterial drugs and vaccines has been hampered because the survival 
strategies employed by M. tuberculosis and its mechanisms of pathogenesis are 
not well understood.  
Protein export pathways are promising therapeutic targets that have yet to 
be fully exploited in this bacterium (108). The M. tuberculosis SecA2 protein is 
one such target. In fact, a ∆secA2 strain of M. tuberculosis promotes apoptosis of 
infected macrophages and shows enhanced priming of CD8+ T cells in mice (94). 
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The combination of lysine auxotrophy and secA2 deletion to produce a ∆secA2 
∆lysA strain of M. tuberculosis was shown to be a strong vaccine candidate and 
was safer and more effective than the traditional BCG (Bacille Calmette-Guérin) 
vaccine for Tuberculosis (95). However, because the role of SecA2 in the 
Mycobacteria, and its implications for virulence are not well understood, the 
development of this vaccine is hindered by stringent pharmacological guidelines. 
This study reports extensive biochemical characterization of SecA2 that sets the 
stage for elucidation of SecA2’s role in Mycobacterial protein secretion. In a 
previous study we showed that SecA2, like SecA1, is an ATPase. It binds ATP 
with high affinity and the ATPase activity of SecA2 is essential for bacterial 
survival in macrophages (43). The factors by which the translocation machinery 
and precursor proteins distinguish the two SecA homologs are not known. SecA 
proteins undergo large conformational changes, particularly involving movement 
of their precursor-binding domain (PPXD) (26,63,76,77). For example, the crystal 
structure of Thermatoga maritima SecA in the ADP bound form shows the PPXD 
rotated towards the helical wing domain (HWD) leaving a large groove open 
between the PPXD and nucleotide-binding domain 2 (NBDII) (76) (Figure 3-1). 
This grove, referred to as the ‘clamp’, is thought to facilitate the binding of the 
precursor protein by SecA (76). Thermatoga maritima SecA bound to the 
SecYEG channel shows a large movement (~ 80º) of the PPXD towards NBDII, 
resulting in the closing of a grove between these two domains (74).  
Here we show that M. tuberculosis SecA2 has a significantly higher affinity 
for ADP, and releases the nucleotide extremely slowly, compared to SecA1. In 
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addition, we find that SecA2 undergoes a large conformational change upon ADP 
binding that is easily observable with standard biochemical techniques. Our data 
suggest that this structural rearrangement is due to closure of the ‘clamp’ in 
SecA2, which may be unique to the accessory SecA class of proteins, as 
nucleotide-binding does not induce this structural change in M. tuberculosis 
SecA1 or E. coli SecA. This may serve as a mechanism for distinction between 
the two SecA proteins by the Mycobacterial translocation machinery.  
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Figure 3-1: Crystal structures of Thermatoga maritima SecA showing two 
conformational states.  
(A) Structure of T. maritima SecA in the ADP-bound form exposing the clamp 
(PDB ID 3JUX) (76). The nucleotide binding domains (NBD) I and II are shown in 
light and dark blue respectively. The pre-protein crosslinking domain (PPXD) is 
shown in orange. The helical scaffold domain (HSD) is shown in tan and the two-
helix finger that is part of the HSD is shown in dark gray. The helical wing domain 
(HWD) is shown in green. (B) Structure of T. maritima SecA bound to the 
channel (PDB ID 3DIN) in presence of ADP- BeF3 (74). In this structure, the 
PPXD has rotated toward NBD II sequestering the clamp. The structure (B) has 
been modified to show only SecA. The program Chimera was used to generate 
these structures based on PDB files (38).  
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Results 
A. SecA2 shows a unique structural change upon binding to ADP. 
Conventional SecA proteins have been shown to undergo conformational 
changes upon nucleotide binding and hydrolysis. These changes are closely 
coupled with precursor binding and release, as well as association of SecA with 
the translocon (26,76). The presence of two SecAs in Mycobacteria raises 
questions about how these homologs are regulated in the cell. Since both 
proteins are ATPases with significant sequence homology, could unique 
conformational changes upon binding nucleotides dictate specific interactions 
with other translocation components? In order to investigate potential structural 
changes, the SecA proteins (without His6 tags) were incubated with increasing 
concentrations of ATP in buffer containing 1 mM MgCl2. Since the effect of 
nucleotides on the conformation of E. coli SecA has been studied extensively, E. 
coli SecA was used as a control. Interestingly, SecA2 showed a dramatic mobility 
shift in the presence of ATP (Figure 3-2). In fact, SecA2 exists as two species in 
equilibrium. In the absence of nucleotides, the slow migrating species 
predominates. The addition of nucleotides shifts the equilibrium to the faster 
migrating form. No shift in mobility was seen with E. coli SecA or SecA1 even at 
high ATP concentrations (Figure 3-2). A Walker A Box variant of SecA2 (K115R), 
which we have previously shown does not bind ATP (43) also did not show a 
mobility shift on the agarose gel. Next, the SecA proteins were incubated with 
varying concentrations of MgCl2 while the ATP concentration was held constant.  
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At very low concentrations of Mg 2+ (below 100 µM), no mobility shift was 
observed, but as the Mg 2+ concentration was increased, the mobility shift of 
SecA2 became apparent however; SecA1, E. coli SecA and SecA2 K115R did 
not show a mobility shift even at high concentrations of Mg 2+ (Figure 3-2). 
Further, the mobility shift shown by SecA2 was not observed when Mg 2+ was 
substituted with divalent cations or when EDTA was included in the buffer (data 
not shown). These data show that the mobility shift of SecA2 is unique and is 
solely Mg+2 • nucleotide-dependent.  
The SecA proteins were further incubated with hydrolyzable nucleotides 
(ADP or ATP) or fluorescently labeled hydrolyzable analogs such as N'–
methylanthraniloyl (MANT) ADP or MANT-ATP in buffer containing Mg 2+ before 
being subjected to native agarose gel electrophoresis. Note that His6 versions of 
SecA1, SecA2 and SecA2 K115R were used in this experiment. Once again, 
SecA2 showed a mobility shift in the presence of ADP and hydrolysable ATP 
analogs but no mobility shift was observed with the non-hydrolysable ATP analog 
(AMP-PNP). No shift in the mobility of the protein bands for either E. coli SecA or 
SecA1 in response to binding of any nucleotide was observed (Figure 3-3 A). 
Additionally, the observation of two discrete bands of SecA2 (especially in the 
His6 version of the protein) on the agarose gel suggests the exchange between 
the species is slow relative to the rate of electrophoresis. 
SecA2, being an ATPase, would hydrolyze ATP to ADP. If ADP release 
were rate limiting, as is the case with E. coli SecA (67,68) then the change in 
SecA2 mobility observed on the agarose gel might be induced by ADP rather 
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than ATP. In the presence of AMP-PNP, only a small fraction of SecA2 shows a 
mobility shift compared to SecA2 bound to hydrolyzable nucleotides or ADP. This 
observation suggests the mobility shift is not due to binding of ATP, but must 
occur further along SecA2’s enzymatic cycle. In order to verify that SecA2 did in 
fact bind AMP-PNP, we used fluorescently labeled MANT AMP-PNP. The MANT 
AMP-PNP binding kinetics were followed by fluorescence resonance energy 
transfer (FRET) between the intrinsic tryptophan residues of SecA2 and the 
MANT nucleotide analog. From the fluorescence traces, it is evident that SecA2 
bound MANT AMP-PNP, and release it when excess unlabeled ATP was added 
(Figure 3-3B). Nevertheless, a mobility shift as seen with hydrolyzable 
nucleotides was not observed when MANT AMP-PNP was incubated with SecA2 
and subjected to agarose gel electrophoresis, consistent with results for 
unlabeled AMP-PNP (Figure 3-3A).  
These data indicate that SecA2 can exist in two structural forms that are in 
equilibrium with each other. Binding of ADP, but not ATP, causes structural 
rearrangements in SecA2 and shifts the equilibrium such that one conformation 
is favored over the other. Furthermore, this change is unique to SecA2, as SecA1 
and E. coli SecA do not show it, despite their ability to bind nucleotides with high 
affinity. Even though E. coli SecA has been shown to undergo conformational 
changes upon nucleotide binding (73,74) these changes do not cause a gel 
mobility shift in our experiments. 
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Figure 3-2: The unique mobility shift of SecA2 on an agarose gel is Mg2+. 
ADP dependent and is observed in SecA2 that is not His6 –tagged. 
A. SecA proteins (~ 6 µM) were incubated with increasing concentrations of ATP 
in buffer containing 1 mM MgCl2 and subjected to native gel electrophoresis on a 
1% agarose gel. The band of SecA2 shows an increase in mobility in the 
presence of ATP that is not observed with E. coli SecA, M. tuberculosis SecA1 or 
a Walker box mutant of SecA2. B. SecA proteins were incubated with increasing 
concentrations of MgCl2 in buffer containing 1 mM ATP and subjected to agarose 
gel electrophoresis.  
 67
 
 
Figure 3-3: SecA2 reveals a unique structural rearrangement on binding 
ADP.  
(A) SecA proteins (~ 6 µM) were incubated with nucleotides or nucleotide 
analogs (0.5 mM) and subjected to native gel electrophoresis on a 1% agarose 
gel. The band of SecA2 shows an increase in mobility in the presence of 
hydrolyzable nucleotides that is not observed with E. coli SecA, M. tuberculosis 
SecA1 or a Walker box mutant of SecA2. (B) Fluorescence traces showing 
increase in MANT-AMP-PNP (1.2 µM) fluorescence upon binding to SecA2 (0.5 
µM) and release upon the addition of unlabeled ADP (1 mM).  
 68
B. ADP bound SecA2 can be separated from nucleotide-free SecA2 using 
Blue-Sepharose chromatography. 
The mobility shift of SecA2 upon nucleotide binding on an agarose gel, a 
distinctly non-equilibrium condition, suggested that the affinity of SecA2 for ADP 
must be quite high. This observation likewise indicated that a fraction of SecA2 
might remain ADP-bound even after purification on the metal affinity column. To 
separate the ADP-bound fraction from the nucleotide-free protein, Cibacron Blue 
F3G-A-Sepharose column (Blue-Sepharose) was used. This dye associates with 
the nucleotide fold found in ATP-binding proteins (109). The column fractions 
were run on a 10% Bis-Tris gel, and SecA2 was observed to elute in two peaks. 
A portion of SecA2 eluted immediately in the flow-through, corresponding to 
SecA2 that did not bind to the blue column. A larger portion of SecA2 bound to 
the column tightly and eluted in 2 M NaCl (Figure 3-4A). An aliquot from each of 
the two peaks was run on a native agarose gel. Based on the mobility of the 
SecA2 band, it is evident that the first peak of SecA2 did not bind to the Blue-
Sepharose column because it was ADP-bound and showed the distinct faster 
mobility on the agarose gel, while the fraction of SecA2 that bound tightly to the 
column was ADP-free and showed slower mobility (Figure 3-4B). 
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Figure 3-4: ADP-bound and free forms of SecA2 can be separated by Blue-
Sepharose chromatography. 
A 10 % Bis-Tris gel of column fractions of SecA2 purified on a Blue-Sepharose 
column. The first peak corresponds to ADP-bound SecA2 that does not bind to 
the column and elutes in buffer without salt. The second peak corresponds to 
ADP-free SecA2 that binds tightly to the column and elutes in 2 M NaCl. (B) The 
two peak fractions from the Blue Sepharose column were subjected to native gel 
electrophoresis on a 1% agarose gel. The fraction of SecA2 that did not stick to 
the column shows the distinct mobility shift verifying that it is ADP-bound. 
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C. SecA2 binds ADP with high affinity and releases it significantly slowly 
compared to SecA1. 
To characterize the interaction between SecA2 and ADP, the kinetics of 
nucleotide binding were assessed using FRET between the intrinsic tryptophans 
of SecA2 (donor) and MANT nucleotides (acceptor). Since MANT nucleotides 
were able to induce a structural rearrangement in SecA2 in a manner similar to 
unlabeled nucleotides (Figure 3-3A), the binding of MANT nucleotides to SecA1 
and SecA2 likely mimics the association of the unlabeled nucleotides with these 
proteins. Additionally, MANT-ATP has been shown to support translocation of 
precursors by the E. coli SecA ATPase in an in vitro translocation assay, 
highlighting that substitution of ATP with MANT nucleotides allows for 
physiologically relevant activity (70). 
The tryptophans of M. tuberculosis SecA proteins were excited, and upon 
binding of MANT nucleotides, the increase in MANT fluorescence due to energy 
transfer was monitored with time (Figure 3-5). The data were fit to a single 
exponential function to obtain the apparent rate constant for association (kobs). 
After binding was saturated, excess unlabeled nucleotide was added to compete 
the MANT nucleotide from the protein. The decrease in MANT fluorescence was 
followed with time. These data were fit with the equation for a first order decay to 
determine the dissociation rate constant (koff). These constants were further used 
to calculate the association rate constant (kon) and the dissociation constant (Kd) 
as described in the Materials and Methods. In order to verify pseudo-first order 
kinetics, kobs was determined at varying MANT-ADP concentrations while the 
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concentrations of SecA1 or SecA2 were held constant. The plot of kobs vs. 
[MANT-ADP] was linear for both SecA1 and SecA2 (Figure 3-5C), indicating that 
binding of MANT-ADP to the SecA proteins follows pseudo-first order kinetics.  
From analysis of the rate constants obtained from single exponential fits 
(Table 3-1), SecA2 showed very slow release of bound ADP (koff  1x10-4 s-1) 
compared to SecA1 (koff 1x10-3 s-1) Also, the affinity of SecA2 for MANT-ADP (Kd 
~ 0.05 µM) was about 120 fold tighter than that of SecA1 (Kd ~ 6 µM). The kinetic 
constants were similar to those obtained from linear regression when kobs was 
plotted as a function of MANT-ADP concentration (Table 3-1) consistent with 
pseudo-first order kinetics. These data suggest the slow release of ADP from 
SecA2 may regulate its function in vivo.  
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Figure 3-5: SecA2 binds ADP with high affinity. 
Kinetics of MANT-ADP binding to SecA1 (A) and SecA2 (B) were assessed by 
FRET between the intrinsic tryptophans in SecA (donor) and MANT-ADP 
(acceptor). The increase in MANT-ADP was monitored with time when 1.2 µM 
MANT-ADP was added to SecA (0.5 µM) in HEPES buffer. MANT-ADP 
dissociation was observed by the addition of 0.5 mM unlabeled ADP. These data 
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were fit to kinetic models as described in the Materials and Methods. (C) Kinetics 
of MANT-ADP binding to SecA1 and SecA2 was observed at varying MANT-ADP 
concentration and the apparent rate constant (kobs) was calculated from single 
exponential fits of the data. Data are plotted to show the variation in kobs with 
MANT-ADP concentration.  
 
 
 
 
 
 
 
 
 
 
 
 74
 
 
 
 
Table 3-1. Kinetic constants for binding of MANT-ADP to M. tuberculosis 
SecA proteins determined by FRET. 
 
 
Protein 
 
(Low salt 
conditions) 
Kinetic constants determined from direct fits to 
rate equations 
Kinetic constants determined from 
plots of kobs vs. concentration of 
MANT-ADP 
kobs  x 10-3 
(s-1) 
koff   x 10-3 
(s-1) 
kon 
(M-1s-1) 
Kd 
(µM) 
koff   x 10-3 
(s-1) 
kon 
(M-1s-1) 
Kd 
(µM) 
SecA1  
(Dimer) 
1.3 1 232 6 1 165 6 
SecA2 
(Dimer) 
2.7 0.1 2 x 103 0.05 0.4 1.6 x 103 0.25 
 
Protein 
 
(High salt 
conditions) 
Kinetic constants determined from direct fits to 
rate equations 
Kinetic constants determined from 
plots of kobs vs. concentration of 
MANT-ADP 
kobs  x 10-3 
(s-1) 
koff   x 10-3 
(s-1) 
kon 
(M-1s-1) 
Kd 
(µM) 
koff   x 10-3 
(s-1) 
kon 
(M-1s-1) 
Kd 
(µM) 
SecA1 
(Monomer) 
3.6 3.5  84 42 1 87 41 
SecA2 
(Monomer) 
3.2 0.12  2.6 x 103 0.05 0.8 1.8 x 103 0.4 
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D. The structural change in SecA2 is not due to changes in oligomeric state  
Change in oligomeric state could reasonably cause a shift in the mobility 
of SecA on an agarose gel. SecA proteins are well documented to undergo 
association reactions (84,85). To investigate the possibility the observed 
structural rearrangements in SecA2 were due to a change in the oligomeric state 
caused by the presence of nucleotides, SecA2 was subjected to size exclusion 
chromatography. This was done in the presence of buffer supplemented with 25 
mM or 300 mM KCl since presence of high salt has been shown to dissociate the 
E. coli SecA dimer (85,86). The elution profiles for SecA2 in the presence of high 
salt or low salt buffers were consistent with the proteins being predominantly 
monomeric in high salt and dimeric in low salt based on calibration standards run 
over the column (Figure 3-6). When the low salt buffer was supplemented with 
ADP or ATP there was no shift in the elution peak of dimeric SecA2 Similarly, no 
change in the elution of the SecA2 monomer peak was observed when the high 
salt buffer was supplemented with nucleotides. Monomeric SecA2, in high salt 
buffer, is able to bind nucleotides with similar affinities to SecA2 in low salt buffer 
(Table 3-1). These data show that nucleotides do not change the oligomeric state 
of SecA2.   
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Figure 3-6: The ADP-induced rearrangement is not due to an oligomeric 
state change. 
 Superdex 200 size exclusion column profiles of SecA2 in the presence of low or 
high salt buffer either with or without added ADP. The elution volumes of the 
peaks of the calibration standards are marked along the top X axis along with 
their corresponding molecular weight. The addition of ADP does not cause a shift 
in the dimer or monomer peak verifying that ADP does not induce a change in 
oligomeric state in SecA2. 
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E. The structural change in SecA2 is not due to changes in surface charge. 
Another determinant of migration on a native agarose gel is surface 
charge of a protein. Since ADP-SecA2 migrates further on the agarose gel 
compared to apo-SecA2, we speculated the conformational change induced by 
ADP could lead to exposure of negative charges or sequestering of positive 
charges on SecA2. In order to test this possibility, limited proteolysis experiments 
were performed in the presence and absence of ADP using V8 protease in 
phosphate buffer at pH 7.6 to allow for specificity for both aspartic and glutamic 
acid residues. Limited proteolysis experiments were also performed using trypsin 
to allow for specificity for lysine and arginine residues. However, no change in 
the protease digestion pattern of SecA2 was observed upon binding of ADP in 
the presence of V8 protease or trypsin. Only increased protection of full length 
SecA2 to V8 digestion was seen showing that nucleotides stabilize the protein 
(Figure 3-7). 
Another approach was taken to further verify the possibility of changes in 
surface charge of SecA2 upon ADP binding. Ion exchange chromatography of 
SecA2 at pH 7.6 using a Hi-Trap Q anion exchange column was performed. 
Altered binding to the Q-column in the presence of ADP, would be indicative of a 
significant change in surface charge. The elution profiles showed no shift in the 
ADP-bound SecA2 peak (Figure 3-8). However; when fractions from each of the 
peaks were run on an agarose gel, samples corresponding to the ADP-bound 
SecA2 showed the distinct mobility shift, confirming that ADP remained bound 
through the column. Even though binding of proteins to an ion exchange column 
 78
is dependent on average surface charge and a shift in elution peak on such a 
column would only occur in case of a drastic overall surface charge change, the 
gel mobility shift observed in response to nucleotides in SecA2 seems like it 
might require such a dramatic charge or conformational change. However, these 
data indicate that the ADP-induced conformational change in SecA2 is likely due 
to a structural rearrangement resulting in a change in the overall shape of the 
protein, rather than a change in oligomeric state or surface charge. 
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Figure 3-7: Limited proteolysis experiments indicate the nucleotide-
induced rearrangement is not due to a change in surface charge. 
Separation of proteolytic fragments of SecA2 alone or in the presence of ATP by 
SDS PAGE using the proteases Trypsin (Top gel) or V8 protease (bottom gel) 
show that there is no change in cleavage pattern of SecA2 in the presence of 
nucleotide. Only increased protection of full length SecA2 to V8 protease in the 
presence of ATP can be seen. The same results are obtained even when ATP is 
substituted by ADP. 
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Figure 3-8: The ADP-induced rearrangement is not due to a change in 
surface charge. 
Hi-Trap Q-column elution profiles for SecA2 in the presence or absence of ADP. 
SecA2 was loaded onto the column under three conditions: 1) A mixture of ADP- 
and apo-SecA2; 2) apo-SecA2; 3) ADP-free SecA2 pre-incubated with ADP for 
30 minutes before being loaded onto the Q column. The column was eluted with 
a linear salt gradient. An aliquot from each SecA2 peak was run on an agarose 
gel (Inset). No shift in the elution peak was observed when SecA2 was 
nucleotide bound indicating that nucleotides do not cause a dramatic change in 
surface charge of SecA2. 
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F. SecA2 is significantly stabilized to heat when ADP bound. 
To further investigate the role of ADP in conformational changes in SecA2, 
circular dichroism spectroscopy was used. The thermal stability of SecA2 was 
assessed in the presence and absence of nucleotide. The CD signal of the highly 
helical SecA2 protein was monitored at 222 nm as a function of temperature and 
the data were plotted to show the fraction unfolded with temperature (Figure 3-9). 
The melting temperature (Tm) was estimated from the mid-point of the transition. 
In the absence of nucleotide, SecA2 showed a Tm of ~ 34 ºC. However, the 
addition of ADP significantly stabilized the protein and caused a shift in the Tm of 
~ 10 ºC. The Tm of SecA2 K115R was 34 ºC and did not change with the addition 
of nucleotide, confirming that nucleotide binding of ADP to wild type SecA2 
confers stability of the protein to heat.  
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Figure 3-9: Binding of ADP enhances thermal stability of SecA2.  
Thermal stability of SecA2 was assessed in the absence and presence of 0.5 
mM ADP by monitoring the circular dichroism at 222 nm with increasing 
temperature. Data are plotted to show the fraction unfolded with temperature. 
ADP binding increases the Tm of SecA2 but does not cause any change in the Tm 
in SecA2 K115R, the Walker box variant of SecA2 that does not bind nucleotide. 
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G. ADP binding confers protection to regions of the pre-protein binding 
domain in SecA2 
To investigate the ADP-dependent conformational change, SecA2 was 
subjected to limited proteolysis by thrombin in the presence or absence of ADP. 
The proteolytic fragments were analyzed by SDS PAGE (Figure 3-10A). When 
ADP-bound, SecA2 showed significant protection to cleavage by thrombin 
compared to the unbound form. In the presence of ADP, there was a new 
proteolytic fragment indicating exposure of a new thrombin cleavage site in 
SecA2, which is consistent with a conformational change in the protein. The 
predominant thrombin cleavage sites on SecA2 (indicated by the arrows in 
Figure 3-10A) were identified by N-terminal sequencing of the fragments by 
Edman degradation.  
Three (blue arrows in Figure 3-10A) out of the four fragments had the 
sequence IAQL at the N-terminus, indicating that the predominant cleavage site 
on SecA2 was the bond between R335 and I336, while the fourth fragment (black 
arrow) had the sequence TTRA, the first threonine being the fourth residue from 
the N-terminus of the protein. The mass of the fragment starting at TTRA is 
consistent with C-terminus cut site at R335. The highest MW band starting with 
IAQL (top blue arrow) is consistent with the entire C-terminus after the cleavage. 
There is another predicted thrombin cleavage site in SecA2 located between 
R502 and G503, which would explain the lowest MW fragment. The fragment 
with MW ~ 40 kDa must be caused by a non-canonical cut site. Regardless, the 
R335 site is protected in SecA2 bound to ADP but exposed in apo-SecA2. When 
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mapped onto a structural model of SecA2 generated using 3D Jigsaw (110) the 
site (blue ball representation) generating IAQL fragments is located in the 
probable pre-protein binding domain (PPXD) of SecA2 (Figure 3-10B). The 
model of SecA2 is overlaid with the structure of T. maritime SecA in the open 
clamp form (76) as well as in the closed clamp conformation of T. maritima SecA 
when bound to the translocon channel (74). From a sequence alignment of T. 
maritima SecA with M. tuberculosis SecA2, the corresponding thrombin cleavage 
site on T. maritima SecA was identified and mapped onto the structures (purple 
ball representation). From comparison of the two overlays, it is evident that this 
region undergoes a dramatic conformational change. We postulate that in the 
ADP-bound conformation of SecA2, this site could be protected if it comes in 
close proximity to the nucleotide-binding domain (NBD2) in a manner similar to T. 
maritima SecA (Figure 3-10B). A hypothesis can be made based on these data, 
that for SecA2, binding of ADP might induce the movement of the PPXD such 
that SecA2 exists in the ‘closed clamp’ state when ADP bound. 
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Figure 3-10: Limited proteolysis of SecA2.  
(A) Cleavage of SecA2 by thrombin with time in the absence and presence of 
ADP. Cleavage products were separated on a 10% SDS gel. SecA2 shows 
increased protection to thrombin in the presence of ADP. The arrows show 
fragments that were subjected to N-terminal sequencing. Fragments shown with 
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blue arrows had the N-terminal sequence IAQL. (B) The predominant thrombin 
cleavage site with the N-terminal IAQL sequence is shown in blue ball 
representation on a model of M. tuberculosis SecA2 (orange) generated using 
the program 3D-JIGSAW (110). The SecA2 model has been overlaid with the 
structure of T. maritima SecA in the open form in gray on the left (PDB ID 3JUX 
(76)), and on the right, the closed form (PDB ID 3DIN (74)). Based on sequence 
alignment, the corresponding thrombin cleavage site on T. maritima SecA is 
shown in purple. The UCSF Chimera program (38) was used to generate the 
figures. 
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H. ADP binding closes the clamp of SecA2 but not of SecA1. 
In order to test whether the mobility shift shown by SecA2 on an agarose 
gel in response to ADP binding could be due to movement of the PPXD to the 
‘closed clamp’ state, the native cysteine residues in SecA1 and SecA2 were 
mutated to serines and two sets of double cysteine mutants were introduced in 
both SecA1 and SecA2 to restrain the PPXD by disulfide bond formation in a 
manner done by the Collinson group (111). Due to high sequence homology 
between E. coli SecA and M. tuberculosis SecA1 we were easily able to make 
the corresponding mutants in SecA1 representing the open clamp 
(D318C:E810C) and closed clamp (D318C:K463C). Position D318 is in the 
PPXD, while E810 is located in the helical scaffold domain, and K463 is in NBD2 
(Figure 3-12). In SecA2, however, due to absence of sequence homology in 
these regions, as well as the lack of a crystal structure of any SecA2 protein, 
generation of cysteine pairs that would mimic the respective conformations 
proved challenging. 
We used S332C:D713C to probe the open clamp conformation of SecA2, 
but had to generate several combinations of cysteine mutants for the closed 
clamp and tested for disulfide bond formation. Position S332 is modeled to be 
located in the PPXD of SecA2, while D713 is modeled in the helical scaffold 
domain. We initially generated S332C:K475C as the closed clamp of SecA2. 
Position K475 would be in NBD2. Disulfide bond formation could not be 
assessed by non-reducing SDS PAGE as a series of higher molecular weight 
bands were observed on the gel. This result cannot be explained as wild type 
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SecA2 as well as several mono cysteine mutants of SecA2 with cysteines in 
different locations also show these bands even in the presence of high salt 
conditions where SecA2 would be monomeric, ruling out the possibility of intra or 
inter-molecular disulfide bonds.  
In order to probe for proximity of the cysteines in a manner that does not 
constrain the cysteine residues, we resorted to pyrene excimer fluorescence. 
Pyrene is a fluorescent probe that has emission peaks between 370 nm and 405 
nm. When two pyrene molecules are within a distance of ~ 10 Å, pyrene rings 
adopt a stacked conformation giving rise to an excited state dimer or ‘excimer’ 
that has an emission peak of ~ 460 nm. The double cysteine mutants 
representing the open and closed clamp variants of SecA1 and SecA2 were 
labeled with N-(1-pyrene)iodoacetamide (Life technologies) via their cysteine 
residues. Under low salt conditions where SecA1 and SecA2 are predominantly 
dimeric, the proteins showed only a peak of pyrene monomer fluorescence and 
no excimer was seen. Since the cysteine residues would be close to the dimer 
interface, perhaps dimerization of the protein affected the stacking of the pyrene 
rings and prevented excimer formation. Under conditions of high salt however, 
where the proteins are mostly monomeric, pyrene excimer fluorescene peaks 
were seen in case of both SecA1 open and closed clamp variants showing that 
the cysteine residues were in close proximity (Figure 3-11). This was also the 
case for the SecA2 open clamp mutant but the closed clamp form of SecA2 
S332C:K475C did not show an excimer peak under high or low salt conditions. 
This mutant of SecA2 also did not show a mobility shift on agaraose gel under 
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oxidizing conditions. This indicated that SC332C:K475C does not represent the 
closed clamp as the cysteine residues are not in close proximity and thus would 
not be able to form a disulfide bond. In order to confirm that the excimer was not 
an artifact caused by the presence of high salt, wild type SecA2 that possesses 
two cysteines was used as a control. The two cysteines are far apart and would 
not be able to form an intramolecular disulfide bond. When wild type SecA2 was 
labeled with N-(1-pyrene)iodoacetamide and then emission scans were 
performed, only typical pyrene monomer peaks were seen between 350 and 450 
nm while no excimer peaks were observed even under high salt conditions. 
Finally we generated S332C:D580C as the closed clamp of SecA2 and D580 is 
in NBD2 (Figure 3-12).  
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Figure 3-11: Probing the proximity of cysteines using pyrene excimer 
fluorescence. 
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Fluorescence scans of SecA1 and SecA2 open and closed clamp variants 
labeled with N-(1-pyrene)iodoacetamide. Scans were performed in buffer with 
high salt in order to probe the proximity of cysteine residues within SecA 
monomers. An excimer peak around 460 nm is indicative of the cysteine residues 
being in close proximity. WT SecA2 that has two native cysteines that are far 
apart and shows characteristic pyrene monomer peaks but does not show an 
excimer peak irrespective of the buffer used. (Inset) A cartoon of the SecA 
protein depicting positions of the cysteine residues and expected disulfide bond 
formation between them.  
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Figure 3-12: Probing clamp regulation in SecA2 using disulfide bond 
formation.  
(A) The crystal structure of M. tuberculosis SecA1 (PDB ID 1NL3 (100)) is shown 
in stereo. NBD I and II are shown in light and dark blue respectively. The pre-
protein crosslinking domain (PPXD) is shown in orange. The helical scaffold 
domain (HSD) is shown in tan and the two-helix finger that is part of the HSD is 
shown in dark gray. The helical wing domain (HWD) is shown in green. The 
cysteines introduced at positions 318 (PPXD), 810 (HWD) and 463 (NBD II) are 
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shown in ball representation in blue, purple and red respectively. (B) The model 
of SecA2 generated using 3D Jigsaw (110) is shown in stereo. Based on 
sequence homology to M. tuberculosis SecA1 and E. coli SecA, the domains are 
colored to match SecA1 shown in (A). The cysteines introduced at positions 332 
(PPXD), 713 (HWD) and 580 (NBD II) in SecA2 are shown in ball representation 
in blue, purple and red respectively.  
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The PPXD in each mutant protein was restrained by disulfide bonds 
between the cysteines by air oxidation, or released using reducing agent. All 
variant proteins were able to bind nucleotide in a manner similar to wild type. 
Strikingly, when the open (D318C:E810C) and closed (D318C:K463C) clamp 
mutants of SecA1 were subjected to agarose gel electrophoresis in the oxidized 
state, a mobility shift was seen when the clamp was forced closed. This was 
similar to our observations with ADP-bound WT SecA2 (Figure 3-12). Consistent 
with our earlier results, ADP alone did not induce this mobility shift in WT SecA1. 
By comparison, in SecA2 the oxidized open clamp mutant did not show a mobility 
shift on the agarose gel. However, a fraction of the closed clamp mutant of 
SecA2 showed faster migration. This is consistent with the observation that ADP-
bound WT SecA2 shifted almost entirely to the fast migrating form. When the 
oxidized SecA2 closed clamp mutant was reduced with TCEP, the faster 
migrating band is lost to the slower migrating band (Figure 3-12). These results 
show that the faster migrating form is only present when the closed clamp mutant 
was air oxidized but was absent when reduced. We expected the closed clamp 
mutant of SecA2 to shift entirely to the fast migrating form when oxidized; 
however, only a fraction shifted. This suggests that the open conformation of 
SecA2, in which the PPXD remains close to the helical wing domain, is favored 
until the protein is ADP bound. Alternatively, in SecA2 the sites chosen for the 
closed clamp cysteines might not be a perfect representation of the true closed 
clamp. Regardless, these results are consistent with the hypothesis that the 
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faster migrating species observed on the gel corresponds to SecA2 in its closed 
clamp form.  
Furthermore in SecA2, but not in SecA1, movement of the PPXD is 
regulated by nucleotide binding.  
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Figure 3-13: Binding of ADP induces movement of the PPXD to close the 
clamp of SecA2 but not in SecA1.  
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(A) Cartoon representation of M. tuberculosis SecA proteins in the open or 
closed clamp forms by disulfide bond formation between pairs of cysteines 
introduced by site-directed mutagenesis. (B) A 1% native agarose gel shows 
SecA1 only shifts mobility to a faster migrating form upon forced closure of the 
clamp by air oxidation of the cysteine residues. SecA2 shows a shift in mobility in 
the presence of ADP or if it’s clamp is forced closed by oxidation of the 
introduced cysteines by air. The faster band that corresponds to the oxidized 
form in the closed clamp mutant of SecA2 shifts back to the slow migrating 
species in the presence of 20 µM TCEP.  
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Discussion 
The identification of an additional SecA protein in several pathogenic 
bacteria has raised questions regarding the role of the accessory SecA in 
precursor translocation. In these systems, since SecA1 and SecA2 are 
functionally distinct (41,92), how are pre-proteins targeted to their respective 
SecA proteins given the redundancy in signal sequences? We set out to 
investigate some basic differences between the two SecA proteins of M. 
tuberculosis with the aim that our study might provide insight into the differences 
in regulation of the two SecA homologues. Our data show that SecA2 binds ADP 
with high affinity and that binding of ADP induces a large conformational change 
in SecA2. Interestingly, nucleotide binding does not induce this change in SecA1.  
Conventional SecA proteins have been shown to undergo rapid ATP 
hydrolysis at the membrane (‘translocation ATPase’ activity) (25) in a reaction 
where ADP release is rate-limiting (67). Association of SecA with the SecYEG 
translocon (68,70) promotes ADP release, and this step is closely coupled to 
translocation of precursor proteins (112,113). From kinetic data using MANT-
ADP, it is evident that SecA2 releases ADP much more slowly than SecA1; 
consequently the affinity of SecA2 for ADP is much higher than SecA1. E. coli 
SecA has been reported to bind MANT-ADP with a kon of 7.8 x 104 M-1s-1 and koff 
of 6.8 x 10-4 s-1 resulting in a Kd of 9 nM (70). Despite higher affinity of E. coli 
SecA for ADP compared to SecA2 (Kd ~ 50 nM), indicating that it would be ADP 
bound in our agarose gel experiments, E. coli SecA does not show a nucleotide-
dependent shift like SecA2 
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The ADP-dependent shift we observe for SecA2 on an agarose gel is a 
unique feature of Mycobacterial SecA2. Crystal structures of M. tuberculosis 
SecA1 in the apo form and when bound to ADP-β-S do not show any significant 
differences, except for a few residues that are directly involved in nucleotide-
binding, suggesting that there were no significant structural changes in SecA1 
upon ADP binding including in the PPXD (100). This is consistent with our 
observation that SecA1 does not change mobility on the agarose gel with binding 
of nucleotide. 
The most dramatic conformational change seen in conventional SecA 
proteins involves the ~ 80º movement of the PPXD with respect to the helical 
wing domain and NDB2 that leads to opening or closing of the ‘clamp’ 
(74,77,111) (Figure 3-1). The clamp is suggested to hold the pre-protein in a 
manner that facilitates interaction of the pre-protein with the tip of a helix known 
as the ‘two-helix finger’ that directs it into the channel during translocation (74,78). 
How movement of the clamp is regulated in conventional SecA proteins is not 
known.  
 Since there is no structure of any SecA2 protein to date, analysis of the 
conformational change in SecA2 by mutagenesis was challenging. Based on 
sequence homology between SecA1 and SecA2, the greatest variation between 
the two proteins lies in the C-terminal domain, while the nucleotide binding 
domains are highly conserved. This led us to believe that the overall domain 
architecture of SecA2 would be similar to SecA1. Consequently the possibility of 
a large unique conformational change in SecA2 completely different than seen in 
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conventional SecA proteins seems unlikely, although it cannot be entirely ruled 
out. Based on biochemical and biophysical studies on conventional SecA 
proteins and analysis of crystal structures it seems likely the mobility shift we 
observe in SecA2 on an agarose gel involves movement of the PPXD. 
Consistent with structural data, our biochemical data suggest that the clamp in M. 
tuberculosis SecA1 remains open in both the ADP-bound and apo- forms of the 
protein, as seen with E. coli and T. maritima SecA proteins. In contrast, in SecA2 
binding to ADP appears to cause closure of the clamp. 
Based on the high affinity of SecA2 for ADP, and the slow Koff, SecA2 in 
the Mycobacterial cytosol of would be primarily ADP bound even in the presence 
of the 1 mM cellular concentration of ATP (43). Since the clamp of SecA2 would 
be closed in this form, it could serve as a mechanism to prevent binding of 
SecA1 dependent pre-proteins to SecA2. In a study done by the Braunstein 
group to determine the subcellular localization of the SecA proteins in 
Mycobacterium smegmatis, SecA1 was found equally distributed between the 
membrane and the cytosol, while SecA2 was predominantly cytosolic (97). Under 
normal growth conditions, SecA1 functions like conventional SecA proteins in 
translocating the majority of pre-proteins across the Sec translocon. Since SecA2 
is not required for general protein export, but is implicated in the export of 
virulence factors (39,96), we hypothesize that under certain conditions when 
SecA2 is required, binding to an unknown factor or pre-protein signal sequence 
could promote ADP release, thereby opening the clamp of SecA2 to enable it to 
accommodate the pre-protein and target it to the membrane for translocation. 
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Our results provide the first evidence of biochemical differences between the two 
SecA homologues, which suggests a mechanism for the cell to distinguish 
between the proteins during translocation. 
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Chapter 4  
 ‘ IT TAKES TWO TO TANGO-OR DOES IT?’ 
Introduction 
The Sec-dependent secretion system in E. coli has been studied 
extensively over the past three decades. In particular, the ATPase protein SecA 
has been well characterized. However; after decades of work on this protein, its 
oligomeric state remains a puzzle to date. E. coli SecA has been shown to fold 
via a dimeric intermediate (114)  and exist in a monomer-dimer equilibrium in 
solution (85,86). This equilibrium is affected by protein concentration, ionic 
strength and temperature. High protein concentration and low ionic strength 
favors dimerization while high ionic strength favors monomerization (85,86). The 
dissociation constant (Kd) for the dimer has been shown to be less that 1 nM by 
single molecule methods (81). At a salt concentration of 200 mM, which is closer 
to physiological conditions, the Kd is increased to 0.28 µM (86). Nevertheless, at 
a cellular concentration of 8 µM (80), E. coli SecA is expected to be 
predominantly dimeric. Biochemical studies have also shown that dimeric SecA 
is required for protein translocation (115-117). Yet several studies show that E. 
coli SecA functions as a monomer during translocation (118) and that ligands 
such as phospholipids (83) and nucleotides (119) monomerize the protein. 
Further, signal peptides have been shown to cause oligomerization in SecA (83) 
in  some studies while other studies show signal peptides favor monomerization 
of SecA (82,86).  
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The fact that dimerization of SecA is affected by ionic strength suggests 
that the contacts between the two protomers must be stabilized by electrostatic 
interactions. The SecA protein has been crystallized from several organisms, 
however the dimer interfaces are different in all the crystal structures (84). Most 
of these structures are those of dimeric SecA and show an antiparallel orientation 
of the protomers in which the C-terminal domains of each protomer face away 
from each other in opposite directions. 
The structure of Thermatoga maritima SecA bound to the translocon has only 
one protomer of SecA however; crystallization conditions including detergent 
treatment could have led to the loss of one protomer.  
Recently, the structure of the SecA1 dimer from M. tuberculosis (1NL3) 
(100) and SecA dimer from B. subtilis  (1M6N) (120) were re-analyzed using a 
bioinformatics program called EPPIC which identifies physiologically relevant 
dimers (87). The authors found that by a 60º rotation about one protomer, one of 
the structures could be converted to the other indicating that dimerization in both 
SecA proteins are mediated by the same contacts. This observation would 
support the theory that extreme N-terminal residues of one protomer would 
contact C-terminal residues (IRA1 regions, scaffold and wing domain residues) of 
the next protomer supporting previous biochemical data. Several groups have 
shown that deletion of the first few N-terminal residues or IRA1 residues (∆783-
795) render E. coli SecA predominantly monomeric (66,115,118,121). Since this 
would imply a rather large interface. SecA proteins would exist in several dimeric 
states involving the main contacts. These states would be dynamic and 
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interconvertible and would explain why different interfaces are seen in different 
crystal structures (87). The authors identified two main structural elements 
involved in N-terminal contacts (87). These elements involve a short helix 
(referred to as α0) and a longer helix (referred to as α1). The contacts made by 
α0 in E. coli SecA were shown to involve mostly hydrophobic interactions while 
contacts made by α1 were shown to involve electrostatic interactions (mainly 
mediated by six charged residues). When α0 was deleted or the six charged 
residues in α1 were changed to alanines (1-6A), the protein still remained dimeric. 
However, the combination  (∆α0,1-6A) resulted in E. coli SecA being monomeric 
even under low salt conditions. 
Even though the contacts involved in dimerization were identified based 
on the structure of M. tuberculosis SecA1, the authors performed all experiments 
on E. coli SecA and conclude that dimerization in all SecA proteins, involve the 
same structural features. The M. tuberculosis SecA1 protein was crystallized as 
a dimer by the Sacchettini group however; 3D electron microscopy (EM) 
reconstructions of the protein revealed that it forms a tetramer. This gave rise to 
two possible dimer configurations referred to as the A-B or A-C dimer by the 
Sacchettini group (100).  Based on the crystal structure, in the A-B dimer, the 
residues involved in dimerization would be mostly hydrophobic in nature while 
the dimer interface in the A-C dimer would be stabilized by electrostatic 
interactions. The A-C dimer was not considered physiologically relevant as 17 
residues involved in dimerization would involve vector-derived residues. The 
dimer of M. tuberculosis SecA1 described by Gouridis et al. using EPPIC, would 
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resemble the A-C dimer in which α0 and α1 would be the main structural 
elements mediating dimerization.  
In this study, I investigated the oligomeric state of the M. tuberculosis SecA1 and 
SecA2 proteins and attempted to identify the structural elements involved in 
dimerization of  SecA1. 
 
 
 
 
 
 
 
 
 
 
 
 
 106
 
 
 
 
 
Figure 4-1: Dimer configurations of M. tuberculosis SecA1 
The A-B dimer of M. tuberculosis SecA1 (1NL3) (100) is shown on the right while 
the A-C dimer configuration is shown on the left. One protomer of the dimer is 
shown in gray while the other protomer is shown in pink. The N-terminal 
elements that are believed to be involved in forming the dimer interface 
according to Gouridis et al. are colored in cyan (α0) and majenta (α1) while the 
C-terminal elements thought to form contacts with the corresponding protomer 
are shown in purple (IRA1). 
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Results and Discussion 
A. Dimerization in M. tuberculosis SecA1 and SecA2 is salt-dependent. 
An important step towards understanding the mechanism of translocation 
by the M. tuberculosis SecA motor and its interaction with the translocon is the 
determination of the oligomeric state of its SecA proteins. Since M. tuberculosis 
SecA1 and SecA2 share only around fifty percent sequence homology with E. 
coli SecA, we sought to investigate the oligomeric states of SecA1 and SecA2. 
Dimerization of E. coli SecA is salt sensitive (81,85,86), so we investigated the 
association states of SecA1 and SecA2 under low salt (25 mM KCl) and high salt 
(300 mM KCl) conditions by size exclusion chromatography. When purified 
SecA1 or SecA2 were subjected to size exclusion chromatography under 
conditions of low salt, both showed elution profiles consistent with the proteins 
being dimeric based on calibration standards. However, in the presence of 300 
mM KCl, the elution volumes of both proteins increased significantly, consistent 
with monomeric forms of the proteins. This indicates that SecA1 and SecA2 
dissociate into monomers in high salt conditions (Figure 4-2).  
Since formation of oligomers is dependent on protein concentration, we 
assessed dimerization of both SecA proteins at varying protein concentrations in 
order to gain insight into the strength of the association. From analysis of the 
column profiles, we confirmed that both SecA1 and SecA2 are predominantly 
dimeric in low salt buffer, even at very low protein concentrations (~0.3 µM) 
indicating that under low salt conditions, the dissociation constant (Kd) for 
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dimerization must be lower than 0.3 µM. This is consistent with E. coli SecA 
which has a Kd  < 1 nM in low salt but is monomeric in high salt. These data also 
show that the dimer interface in M. tuberculosis ScA1 and SecA2 must be 
stabilized by electrostatic interactions. 
Since conditions of high salt mimic physiological conditions, the self-
association reactions of SecA1 and SecA2 were further studied in high salt using 
sedimentation velocity analytical ultracentrifugation. The peak fractions from the 
size exclusion column were concentrated and subjected to analytical 
ultracentrifugation at multiple protein concentrations. In order to gain insight into 
the stoichiometry and heterogeneity of the samples, as well as get a rough 
estimate of the sedimentation coefficients, the time derivative method (‘dc/dt’) 
was used (122). Normalized sedimentation coefficient distributions g(s*) for 
SecA1 and SecA2 generated by this method show that for both SecA1 and 
SecA2, the sedimentation coefficients shift towards higher S values with 
increasing protein concentration, indicating that the two proteins undergo self-
association; however, the proteins exist in a weak monomer-dimer equilibrium in 
high salt. The sedimentation coefficient of the monomer was determined to be 
5.25 S for SecA1 (Figure 4-2C) and 5.01 S for SecA2 (Figure 4-2D). In order to 
determine the equilibrium constants (Kd) for the dissociation reactions, the 
sedimentation velocity data were analyzed with the program Sedanal (122). For 
SecA1, a monomer-dimer self-association model was used to fit the data and the 
dissociation constant (Kd) obtained from the fit was approximately 64 µM. Since 
preliminary analysis of the data for SecA2 indicated the presence of aggregates 
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(~ 7% by weight), the data were fit to a monomer-dimer self-association model 
including the presence of a fixed amount of aggregate. From the fit, the Kd for 
SecA2 self-association in high salt was approximately 240 µM. In case of both 
SecA1 and SecA2, the overall fits were good and had RMS errors of 0.002 and 
0.0017 fringes respectively.  
Interestingly, E. coli SecA has a Kd  of ~ 3 µM under conditions of 300 mM 
KCl at 20 ºC (86). This is still below the concentration of E. coli SecA in the cell 
suggesting that under physiological conditions, E. coli SecA would be primarily 
dimeric in the cytosol. On the other hand, our data indicate that the Kd s for 
SecA1 and SecA2 oligomerization are much higher than the respective 
mycobacterial SecA concentrations in the cell suggesting that in the salt 
environment of the cytosol both proteins may be monomeric at least in the 
absence of interaction with pre-proteins, lipids or SecYEG. 
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Figure 4-2: Oligomeric state of M. tb SecA1 and SecA2  
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(A) Size exclusion chromatography column profiles of SecA1 and SecA2 run on a 
Superdex 200 column in buffer with 25 mM KCl (low salt) or 300 mM KCl (high 
salt). (B) SecA1 and SecA2 were run on the column at varying protein 
concentrations in low salt buffer. The traces of SecA1 and SecA2 in high salt are 
shown again in green on this profile to denote the elution volume of the 
monomeric protein. Self-association of M. tb. SecA1 (C) and SecA2 (D) 
characterized by sedimentation velocity analytical ultracentrifugation. The plots 
show the normalized sedimentation coefficient distributions g(s*) for SecA1 and 
SecA2 at increasing concentrations, as analyzed by DCDT+. 
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B. SecA1 does not exist as a salt resistant dimer  
In a study by Kusters et al. (81) to investigate the oligomeric state of SecA 
during various stages of translocation, they found that monomeric SecA binds to 
SecY in a salt-resistant manner, while association of the second protomer was 
salt sensitive. Recently, a study by Gouridis et al. suggested that SecA exists 
mainly in two dimeric forms; in one form the dimer interface is stabilized by 
electrostatic interactions mediated by the α1 region while the other conformer is 
mostly stabilized by hydrophobic interactions mediated by α0 (87). The former 
was referred to as the ‘electrostatic dimer’ (ED) while the latter was called the 
‘salt-resistant dimer’ (SRD). Even though ~ 95 % of E. coli SecA dissociated into 
monomers under high salt conditions, around 5 % remained dimeric. This dimeric 
conformer was believed to be that of the SRD. In our experiments with M. tb 
SecA1 we do not observe a SRD form under high salt conditions however; in 
SecA2 around 5 % of the protein remains dimeric in 300 mM KCl and may 
represent the SRD form (Figure 4-2A). It was also shown by Gouridis et al. that 
by mutation of six charged residues in α1 to alanines (1-6A), the protein still 
remained dimeric in low salt. Under high salt conditions around 50% of the 6A 
protein did not monomerize but remained dimeric. This was attributed to the fact 
that upon mutation of the charged residues, dimerization could still be mediated 
by the hydrophobic α0 region favoring the SRD.  
In order to test if this was true for M. tb SecA1 as suggested by the 
authors, the corresponding charged residues in SecA1 were changed to alanine 
residues and the SecA1_6A protein was subjected to size exclusion 
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chromatography under conditions of low and high salt.  Our data show that under 
low salt conditions, the elution volume of the M. tb SecA1_6A mutant is 
significantly increased compared to WT SecA1 (Figure 4-3). This is unlike the 
case with E. coli SecA; where the 6A mutant does not show any shift in elution 
volume compared to WT, consistent with it being dimeric in low salt. On the other 
hand; under high salt conditions, the peak of M. tb SecA1_6A perfectly overlaps 
with that of the WT protein. This suggests complete monomerization of the 
protein in high salt like WT SecA1 without any evidence of a SRD peak, unlike 
the 6A mutant of E. coli SecA where ~ 50% of the protein remains dimeric (SRD) 
even in high salt. Since SecA1 does not show evidence of a SRD, we wanted to 
test the contribution of the probable α0 region so we made SecA1∆α0 as well as 
SecA1∆α0, 6A however deletion of the α0 region in SecA1 led to rapid 
proteolysis of the protein and analysis of the mutants could not be carried out as 
a consequence.  
Nevertheless, our data suggest that dimerization may not be mediated by 
the same elements in all SecA proteins. In M. tb SecA1, the dimer seems to be 
stabilized mainly by electrostatic interactions. In order to identify the interface, 
cysteine residues could be introduced into the SecA1 protein in a cysteine free 
background, at probable dimer contact sites and disulfide or chemical cross 
linking reagents could be used to identify disulfide-linked dimers. Since the 
dissociation constants for dimerization of SecA1 and SecA2 under physiological 
salt concentrations are not as low as that of E. coli SecA suggesting that the 
proteins in the mycobacterial system may be monomeric, it would be interesting 
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to probe the oligomeric state of these proteins in the presence of other ligands 
like SecY or precursor proteins.  
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Figure 4-3: M. tb SecA1 does not form a salt-resistant dimer 
(Top) An alignment of the first 40 residues of E. coli SecA (EcSA) and M. tb 
SecA1 (SA1) using Clustal is shown. Conservation is represented by the symbols 
below the alignment. Stars represent the same residue while bullets represent 
similar residues. Above the alignment, the regions of the N-termina helices 
representing α0 and α1 according to Gouridis et al.(87) are shown in blue. In the 
SecA1_6A mutant the alanines that substituted the charged residues are shown 
in red. (Bottom) Size exclusion column profiles of WT SecA1 in 25 mM KCl (pink 
trace) and 300 mM KCl (green trace) are shown. Absorbance traces for the 
SecA1_6A mutant in 25 mM KCl and 300 mM KCl are shown in blue and red 
respectively 
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Chapter 5 
 
ASSOCIATION OF THE M. tb SECA PROTEINS WITH MEMBRANES 
 
Introduction 
The presence of an additional SecA protein in M. tuberculosis as well as 
several pathogenic bacteria raises several questions regarding the role of the 
‘accessory’ SecA. In M. tuberculosis, SecA2 is functionally distinct from SecA1 
as deletion of secA2 attenuates bacterial virulence (92). Also, the ATPase activity 
of SecA2 has been shown to be important for the intracellular survival of the 
bacteria in macrophages (43). SecA2 has shown to localize to the cytosol unlike 
SecA1, but a Walker A box variant of SecA2 switches localization to the 
membrane in vivo (97). Similar results are seen with the corresponding Walker A 
box variant in Clostridium difficile, a bacterium that possesses a SecA2 protein 
without a SecY2 (45). These results suggest that the role of SecA2 is probably 
not just restricted to the cytosol instead, it gets recruited to the membrane under 
some condition that is yet to be identified. Since mycobacteria lack a secY2 
homolog, mycobacterial SecA2 is thought to work with the canonical SecYEG 
translocon. Further evidence for this comes for the fact that strains of M. 
tuberculosis, M. smegmatis as well as C. difficile containing a Walker A box 
variant of SecA2 exhibit a dominant negative phenotype (97). Extragenic 
suppressor mutations of the SecA2 K129R Walker A box variant in M. smegmatis 
could be mapped to the SecY promoter region that leads to overexpression of 
the canonical SecY protein (98) and can alleviate the secA2 K129R phenotype. 
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Since SecA2 is thought to function at the translocon at some stage, possibly 
during the export of virulence factors, the questions arise; how is SecA2 
differentiated from SecA1 and recognized by SecY and precursor proteins? What 
is the oligomeric state of SecA2 during translocation? 
Answers to these questions are not yet known due to several difficulties 
associated with studying mycobacterial components in vivo. M. tuberculosis 
grows extremely slowly and is a pathogen that requires biosafety level 3 (BSL3) 
practices. Genetic manipulation of mycobacteria is also not as trivial as it is in E. 
coli. Additionally, since secA1 is essential, it is difficult to study the role of SecA2 
independently in vivo. In order to study the dependence of pre-proteins on SecA2, 
oligomeric state of SecA2 during stages of translocation, association of SecA2 
with membrane lipids and SecYEG, it is essential to have a system reconstituted 
from purified components in vitro. This would allow the study of the SecA 
proteins independently as well as with other ligands such as pre-proteins, lipids. 
One could also vary salt concentrations to favor monomers or dimers of the SecA 
proteins. 
Several attempts were made to express M. tuberculosis SecYEG in E. coli 
using different expression vectors and varying expression conditions; however 
due to rapid proteolysis of SecY in all cases, this was not feasible. Finally, 
vesicles were made from a strain of M. smegmatis that contains hemagglutinin 
(HA) tagged SecY in addition to the endogenous SecY on the chromosome. M. 
tuberculosis secA2 can complement a M. smegmatis ∆secA2 strain and M. 
smegmatis secA2 can substitute for M. tb secA2 during growth of M. tb in 
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macrophages and restore the rough colony phenotype to a M. tb ∆secA2 strain 
(which shows a smooth colony phenotype) (92,97). Since these results 
demonstrate the functional conservation between the two systems we believe 
that the M. tb SecA1 and SecA2 proteins will be able to function along with 
membrane vesicles containing M. smegmatis translocon components. 
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Results and Discussion 
 
A. Membrane vesicles containing HA-tagged M. smegmatis SecY are sealed 
and can establish a proton gradient. 
Generation of sealed membrane vesicles with SecYEG incorporated 
would have several applications in the study of Mycobacterial protein export. 
These vesicles could be used to develop an in vitro translocation assay, similar 
to assays used to study export in E. coli. However; the presence of an unusually 
thick cell wall in Mycobacteria comprised of a layer of mycolic acids makes the 
generation of membrane vesicles challenging.  
Following the protocol of Haagsma et al. (123,124) with a few 
modifications, membrane vesicles of M. smegmatis were obtained. In order to 
check if these vesicles were sealed, the establishment of a proton gradient using 
various substrates was tested by the 9-amino-6-chloro-2-methoxyacridine 
(ACMA) quenching method (123). ACMA is a lipophilic dye that is fluorescent 
when bound to membranes (125). The establishment of a proton gradient across 
membranes due to components of the electron transport chain (ETC) upon 
addition of electron donors, causes quenching of ACMA fluorescence.  
Upon addition of the substrate (NADH, succinate or ATP) to the M. 
smegmatis vesicles, the ACMA fluorescence was quenched with time. Further, 
the addition of an uncoupler carbonyl cyanide m-chlorophenyl hydrazone (CCCP) 
caused the ACMA fluorescence to increase again, indicative of the collapse of 
the proton gradient by the uncoupler (Figure 5-1).  
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When NADH or succinate were used as electron donors, the proton 
gradient was successfully established and collapsed by the addition of CCCP as 
observed by Haagsma et al. (124) indicating that the M. smegmatis vesicles 
generated are functional. However; when Mg2+- ATP was used as a substrate, no 
significant quenching of ACMA fluorescence was observed, consistent with 
results seen by Haagsma et al. and fluorescence did not increase upon the 
addition of uncoupler (124). Since the F1F0 ATP synthase in M. smegmatis 
cannot hydrolyze ATP to make a proton gradient like the case with some 
Mycobacteria, the absence of a proton gradient with ATP as a substrate serves 
as a negative control for this assay (Figure 5-1).  
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Figure 5-1: Establishment of a proton gradient across M. smegmatis 
vesicles assessed by ACMA fluorescence quenching. 
M. smegmatis vesicles (MVs) were treated with the dye ACMA, followed by the 
addition of NADH, ATP or succinate as electron donors. Once the fluorescence 
was fully quenched, the uncoupler CCCP was added (indicated by the respective 
colored arrow) which caused a collapse in the proton gradient and consequent 
increase in ACMA fluorescence.     
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B. SecA1 interacts with the membrane while SecA2 does not. 
In E. coli, the number of copies of SecA (13,000 copies) greatly exceeds 
that of SecYEG  (500 copies) (63). The presence of an additional functionally 
distinct SecA protein in Mycobacteria that is expressed at similar levels to the 
canonical SecA (43) made us question how SecA1 might function at the 
translocon without competing with SecA2 for the limited number of translocon 
sites. On the other hand, since Mycobacteria do not possess a SecB homolog, 
there has been speculation about SecA2’s ability to fulfill the role of a 
cytoplasmic chaperone (126). In order to gain insight into the subcellular 
localization of SecA1 and SecA2, association of these proteins with membranes 
and SecY was tested using M. smegmatis vesicles incorporating HA-SecY.  
Membrane vesicles were checked for the establishment of a proton 
gradient using ACMA quenching by succinate as the electron donor (Figure 5-
2A). Incorporation of HA-SecY into the vesicles was tested by separating the 
proteins from the membrane vesicles by SDS PAGE followed by Western blotting 
using antibodies to the HA tag (Figure 5-2B). The vesicles showed successful 
incorporation of HA-SecY and were sealed indicated by quenching of ACMA 
fluorescence by the addition of succinate and re-establishment of the proton 
gradient upon addition of CCCP (Figure 5-2).  
Iodixanol (OptiPrep) density gradients were set up so that following 
centrifugation, membrane vesicles would float and would be located in the top 
fractions while proteins would remain in the bottom fractions upon fractionation of 
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the gradients. Our data clearly show that when membrane vesicles are present, 
SecA1 shows movement to the top fractions indicating associations with the 
membrane vesicles. SecA2 however, remains in the bottom fractions and does 
not associate with the vesicles (Figure 5-3). These data are consistent with 
western blotting data from the Braunstein lab that show that SecA1 is equally 
distributed between the membrane and the cytosol while SecA2 is mostly 
cytosolic in both M. tuberculosis and M. smegmatis (97). Further, our data show 
that SecA1 can associate with the membrane independently and does not 
require SecA2 or any other factor such as pre-proteins for recruitment to the 
membrane, while SecA2 may either function in the cytosol or require an 
additional factor for recruitment to the membrane. 
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Figure 5-2: M. smegmatis vesicles containing HA-tagged SecY are sealed 
and can maintain a proton gradient. 
A. The M. smegmatis vesicles (MVs) were tested for their ability to maintain a 
proton gradient by the ACMA assay as a method to check if the vesicles were 
sealed. B. Since the strain of M. smegmatis used to prepare the MVs has 
hemagglutinin tagged SecY in addition to endogenous SecY, the incorporation of 
HA-SecY into the vesicles was checked by separating the proteins in the vesicles 
by SDS PAGE followed by western blotting using anti-HA antibodies.  
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C. SecA2 K115R associates with membrane vesicles more than WT SecA2. 
 
Studies have shown that the Walker box variant of SecA2 in M. 
smegmatis (SecA2 K129R) has a dominant negative phenotype and SecA2 
K129R shifts localization to the membrane fraction compared to WT SecA2 
which is cytosolic. When M. tuberculosis SecA2 K115R was tested for 
association with membrane vesicles, a small fraction of the protein was found in 
the membrane fraction. The membrane associated protein fraction was more 
than wild type SecA2 but significantly less than the fraction of SecA1 that shows 
association with membranes (Figure 5-3).  
Since SecA1 is thought to function as the ‘housekeeping’ SecA in general 
protein export, we reasoned that perhaps SecA2 requires SecA1 for recruitment 
to the membrane. SecA1 and SecA2 or SecA2 K115R were incubated together 
before testing membrane association using the OptiPrep gradients, however 
SecA2 did not show recruitment to the membrane fraction even in the presence 
of SecA1, while SecA1 migrated to the membrane fraction. SecA2 K115R did not 
showed any enhancement of membrane binding with the addition of SecA1. 
These data show that SecA1 does recruit SecA2 to the membrane. SecA2 may 
either function in the cytosol or require an additional factor for recruitment to the 
membrane. 
In order to test the possibility that SecA2 requires association with another 
protein or factor for recruitment to the membrane, the proteins SecA2 and SecA2 
K115R were supplemented with M. smegmatis cytosol in addition to the 
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membrane vesicles prior to centrifugation and resolution of the gradients. 
However; neither did SecA2 show recruitment to the membrane nor SecA2 
K115R show enhanced association with membranes even in the presence of 
cytosol (Figure 5-3). Membrane association was also tested in the presence of 
various other factors (data not shown) such as nucleotides (ATP, ADP, AMP-
PNP), proton gradient, precursor proteins and other potential binding partners 
(protein 3311), however unlike SecA1, SecA2 did not show recruitment to the 
membrane under any of the conditions tested. It occurred to us that M. 
smegmatis vesicles would have endogenous SecA bound to it that may occlude 
binding of added SecA1 and SecA2 so membrane association was tested using 
urea treated vesicles however; we did not observe association of SecA2 with 
membranes even when binding sites of M. smegmatis SecY were available.   
Since SecA2 appears to function in the export of virulence factors, it is 
necessary to detect association of a pre-protein with SecA2 in vitro and test 
membrane binding of the SecA2-precursor complex. Due to the fact that SecA2 
Walker A box variants in M. smegmatis, M. tuberculosis and C. difficile shift 
localization to the membrane fraction in vivo, it would be interesting to probe the 
features of these mutants that recruit them to the membrane fraction. Perhaps 
recruitment is mediated by a downstream effector that is yet to be identified. 
Nevertheless, the presence of two SecA homologs, one that interacts with the 
translocon routinely and the other that may only interact transiently suggests that 
SecY in this system would have also evolved to facilitate such interactions that 
must be rather unique. 
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Figure 5-3:  M. tb SecA1 associates with the membrane while SecA2 does 
not. 
M. tuberculosis SecA1, SecA2 or SecA2 K115R was tested for association with 
M. smegmatis membrane vesicles (MVs) using Opti-Prep floatation gradients. 
MVs were found in the top fraction (T) while proteins were localized to the bottom 
fraction (B). Association of SecA1 with membranes caused a shift in migration to 
the top fractions. SecA2 K115R showed a slight association with MVs compared 
to WT SecA2. The addition of M. smegmatis cytoplasm or SecA1 did not recruit 
SecA2 to the membranes or enhance the migration of SecA2 K115R to the 
membrane fraction. 
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SIGNIFICANCE OF THIS STUDY 
Every second, a new person in the world is infected with Mycobacterium 
tuberculosis, the causative agent of Tuberculosis (TB). In fact, around 2 billion 
people are believed to harbor latent TB (127) and around 1.8 million people 
succumb to the disease each year. Even though the causative agent of TB was 
identified by Robert Koch over a century ago in 1882, the disease continues to 
be a leading infectious disease killer and attempts to combat it have proved to be 
difficult due to the survival strategies employed by this bacterium. Recently, the 
emergence of multi drug resistant (MDR) and extensively drug resistant (XDR) 
strains of the bacterium has caused world-wide concern. TB is an airborne 
disease that is acquired through inhalation of the bacteria. The bacteria are 
engulfed by alveolar macrophages resulting in infection foci in the tissue of the 
alveolar wall. Most bacteria are destroyed after being engulfed by alveolar 
macrophages; however mycobacteria have evolved strategies to evade 
destruction by these host cells. M. tuberculosis arrests phagosome maturation 
and thereby prevents its destruction in the lysosome. Instead, these bacteria 
survive and replicate in the host macrophage (128). Growth of the foci due to 
bacterial replication leads to recruitment of macrophages and lymphocytes 
resulting in granuloma formation. Even though this prevents the spread of the 
bacteria, it also protects the bacteria from other host immune cells and 
contributes to the survival of the bacteria in a latent mode (128). Being ‘walled 
off’, the bacteria are also protected from drugs and other agents. Inhibiting M. 
tuberculosis growth is also difficult due to the fact that mycobacteria have an 
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unusually thick outer wall made of mycolic acids. They are also naturally resistant 
to antibiotics and chemicals due to production of beta-lactamases (129).   
Currently, the only licensed vaccine against TB is the Bacille Calmette 
Guérin (BCG) vaccine. Although this live attenuated vaccine from Mycobacterium 
bovis is somewhat effective in preventing widespread TB infection especially in 
children, the benefits and negative aspects of the vaccine have been debated 
extensively. Being a live attenuated vaccine, it has the ability to cause 
disseminated infection in immuno-compromised hosts (130,131). Additionally, the 
vaccine is not very effective in preventing pulmonary tuberculosis. BCG also 
does not confer sufficient immunity as it does not stimulate the appropriate 
populations of T cells (130). Therefore, there is an urgent need for a better 
vaccine against TB. 
Deletion of the secA2 gene has been shown to render M. tuberculosis 
highly attenuated and proapoptotic (132). Recently, two promising vaccine 
strains of M. tuberculosis were developed that have a deletion of the secA2 gene. 
The first strain has a lysine auxotrophy mutation (∆lysA) combined with deletion 
of secA2 (∆secA2) (95). The strain was attenuated in SCID mice and showed 
enhanced apoptosis of host macrophages. Also mice vaccinated with this strain 
showed enhanced CD8+ T cell priming and immunity as they resisted infection by 
M. tuberculosis when challenged (95). Since TB infection is the leading cause of 
death in people with HIV (Human Immunodeficiency virus)-1 infection, this 
vaccine strain was further tested for immunogenicity in mice when engineered to 
express a HIV envelope antigen. The strain was able to generate CD8+ T cell 
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responses against both HIV and M. tuberculosis in neonatal mice (133). Recently 
another vaccine strain of M. tuberculosis was developed that combines deletion 
of replication genes (panCD and leuCD) with deletion of secA2.  A plasmid for 
expression of simian immunodeficiency virus (SIV) Gag protein was introduced 
into this strain. The strain was found to be safe as it did not cause disease and 
induced persistent antibody responses in infant macaques (134). These strains 
are promising candidates for the replacement of BCG as a safe and effective 
vaccine against TB. Since attenuation of virulence is mainly conferred by deletion 
of secA2, but the function of SecA2 and its role in bacterial virulence is still 
unknown, progress and development of these vaccines will be hindered by 
stringent pharmacological guidelines.  
This study represents a biochemical analysis of the SecA2 protein in an 
attempt to decipher its function. SecA2 represents the ‘accessory’ SecA protein 
due to the fact that the secA2 gene unlike secA1 in M. tuberculosis is not 
essential for viability. In order to gain insight into the role of SecA2, the atypical 
features of this protein were probed. In an earlier study, we showed SecA2  can 
bind and hydrolyze ATP in vitro and the ATPase activity of SecA2 is critical for 
the survival of M. tuberculosis in macrophages (43). This study shows that both 
SecA1 and SecA2 bind nucleotides but SecA2 binds ADP with much higher 
affinity and releases the nucleotide much more slowly compared to SecA1. ADP 
also induces a dramatic conformational change in SecA2 involving closure of the 
precursor binding groove as a result of the rotation of the precursor binding 
domain (PPXD or PBD) towards the nucleotide binding domain 2 (NBD2). This 
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nucleotide-induced movement is unique to SecA2 and is not induced in SecA1 
upon ADP binding.  
This study also shows that SecA2 does not associate with membrane 
under normal conditions and cannot be recruited to the membrane by SecA1. On 
the other hand, SecA1 associates with the membrane by itself. These data 
consistent with results from SecA1 and SecA2 localization studies in vivo done 
by the Braunstein group. Based on results from my study, a model for Sec-
dependent export of pre-proteins can be put forth (Figure 6-1). Under normal 
growth conditions in M. tuberculosis, SecA2 would be localized to the cytosol 
while SecA1 would associate with the membrane and function to export proteins 
across the SecY translocon. Due to high affinity of SecA2 for ADP (Kd ~ 50 nM) 
even under high salt conditions, cytosolic SecA2 would be ADP bound owing to 
the high ADP concentrations in the cytosol. Since the interaction of SecA with 
precursors is not sequence specific, but rather involves regions from both the 
signal sequence and mature regions (135), it is unknown how mycobacterial 
precursor proteins not only recognize SecA but distinguish between two SecA 
proteins. However; since cytosolic SecA2 would be ADP bound, the precursor-
binding groove in SecA2 would be occluded preventing it from interacting with 
pre-proteins allowing SecA1 instead to associate with these precursors. Under 
certain conditions, perhaps during infection or for the export of a specific type of 
pre-protein when SecA2 is required, ADP release would be stimulated by a factor 
(yet to be identified). This could open the pre-protein binding groove by rotation 
of the PPXD away from NBD2, towards the HWD (helical wing domain). 
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Precursor-bound SecA2 would be targeted to the membrane where it would 
function in the export of the pre-protein across the SecY translocon either by 
itself or with the aid of SecA1.  
This study paves the way for future studies on SecA2-precursor 
interaction. Identification of the features that distinguish SecA2-dependent pre-
proteins from SecA1 precursors, as well as identification of the factor that would 
target SecA2 to the membrane, would further shed light on the role of SecA2 in 
export of virulence factors. M. smegmatis membrane vesicles (MVs) described in 
this study could be used to set up an in vitro translocation assay for investigation 
of SecA1 and SecA2-dependent export and association with SecY. Since SecA2 
is thought to play an important role in export of virulence factors, identification of 
the role of SecA2 would not only shed light on mechanism of pathogenesis of M. 
tuberculosis but also pave the way for the development of drug targets and 
vaccines against TB.  
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Figure 6-1: Model to explain Sec-dependent translocation in M. 
tuberculosis 
Description can be found in the text. 
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